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ABSTRACT 
 
 Advances in analytical chemistry have led to the detection of low 
concentrations of pharmaceuticals and personal care products (PPCPs) in 
wastewater treatment plant effluents as well as their receiving waters.  
Antidepressants are routinely found among these contaminants, but have been 
shown to be relatively non-toxic at environmentally measured concentrations 
using traditional toxicity testing techniques.  The neurochemical mode of action of 
antidepressants warrants investigation of the effects these chemicals may have 
on fish behavior due to the highly conserved nature of neurotransmitter 
transporter targets.  Using a predator prey bioassay designed in our laboratory, 
previous studies has shown that the antidepressant fluoxetine (Prozac®) causes 
significant effects on hybrid striped bass ability to capture prey.  Increased time 
to capture prey was also correlated with decreasing brain serotonin 
concentrations.  The goal of my dissertation was to expand our knowledge on the 
effects of antidepressant contaminants on the predation behavior and brain 
chemistry of hybrid striped bass (bass).  Bass were exposed to the 
antidepressant fluoxetine for 27 days to determine if exposure duration has an 
effect on the behavioral toxicity of this chemical.  We found that fluoxetine was 
only toxic at the same threshold found in our previous six day exposure studies 
and that longer term exposures did not decrease effective concentrations.  Bass 
were exposed to the antidepressant venlafaxine (Effexor®) for six days followed 
by a six day recovery period at concentrations of 50, 250, and 500 µg/L.  
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Concentrations of 250 and 500 µg/L had a significant effect on the time to 
capture prey 1-3 by day six while the 50 µg/L treatment only had a significant 
effect on bass ability to capture prey 3.  Bass were able to recover their ability to 
capture prey 1 and 2 but time to capture prey 3 remained elevated for all 
treatments after six days of depuration.  Venlafaxine had a significant effect on 
brain serotonin concentrations, which decreased in a dose dependent manner on 
day three and reached a basal level for all treatments on day six.  Results 
indicated that venlafaxine may affect appetite at low concentrations and 
locomotor activity at high concentrations.  Using the concentrations that caused a 
15% decrease in brain serotonin concentrations from our previous studies with 
individual exposures to fluoxetine and venlafaxine, a simple mixture exposure 
was performed with 1 toxic unit representing 15 µg/L of fluoxetine and 25 µg/L of 
venlafaxine.  Concentrations of 1, 2, and 4 toxic units caused a significant 
increase in the time to capture prey 2 and 3 by day six.  Brain serotonin 
concentrations reached a basal level for all mixture treatments by day three and 
remained decreased through day six.  There was a strong exponential correlation 
between brain serotonin concentrations and time to capture prey 1 and 2 on day 
six.  When comparing mixture results to the results of individual antidepressant 
exposures, the data indicated low concentration mixtures may act in an additive 
manner causing increased time to capture prey and decreased brain serotonin 
concentrations at half the respective concentrations of each of the individual 
compounds.  But this effect did not increase for the higher mixture exposure 
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concentrations.  Overall, the results of my dissertation indicate that 
antidepressants, even when present in low concentration mixtures, may present 
a significant risk aquatic organism behavior.  Because effects on behavior can 
impact the fitness of an organism both directly and indirectly, it has implications 
for the population level.  Though behavior is not typically used as an endpoint for 
risk assessment of aquatic contaminants, the behavioral mode of action of 
antidepressants and results of this study may warrant their inclusion. 
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CHAPTER ONE: LITERATURE REVIEW 
Pharmaceuticals and Personal Care Products in the Environment 
 In the past fifteen years advances in analytical chemistry have allowed for 
detection of low concentrations of contaminants in the environment.  Among the 
contaminants regularly found in aquatic ecosystems are pharmaceuticals and 
personal care products (PPCPs).  Both over the counter and prescription 
pharmaceuticals from many different classes, including analgesics, 
antidepressants, hormones, and antibiotics have been found in wastewater 
treatment plant (WWTP) effluent and their respective receiving waters [1].  In 
addition to pharmaceuticals, detected compounds include those typically found in 
products that are used on a daily basis for personal care.  These include anti-
microbials found in hand soap, such as triclosan, and fragrances used in 
perfumes, colognes, and soaps. Concentrations of PPCP’s typically found in 
WWTP effluent and receiving water vary by compound but can range from the 
low nanogram per liter (ng/L) to the low microgram per liter (µg/L) level [1-6].   In 
addition to PPCP’s some researchers have found detectable concentrations of 
illicit drugs in wastewater effluents that can be indicative of drug usage trends in 
large cities [7-10].   
Sources of PPCPs in the Environment 
 The source of PPCPs in the environment can be traced to identifiable 
inputs such as WWTP effluent (point sources) or can be from unknown origins 
such as agricultural runoff (non-point source).  Perhaps the largest input is 
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through regular use in humans.  Studies have shown that up to 90% of some 
pharmaceuticals taken into the body do not reach their target sites and are 
excreted in the parent form [11].  Other pharmaceuticals can be metabolized in 
the body and excreted into our sewage systems as both active and inactive 
conjugates [12].  In addition to direct human use, unused PPCPs are often 
disposed of in toilets adding a significant quantity of these compounds to our 
sewage [13]. Once they reach WWTPs, conjugated pharmaceuticals can be de-
conjugated by microorganisms during treatment resulting in parent compounds in 
final treated wastewater effluents [14].  Whether metabolized or un-metabolized, 
used or un-used, human pharmaceutical use introduces a complex mixture of 
PPCP’s into waste streams that ultimately end up in our wastewater treatment 
plants (WWTP’s).   
 However, most modern WWTP’s are not equipped to remove all 
pharmaceuticals found in waste water.  Some PPCPs are resistant to 
biodegradation in typical activated sludge sewage treatment plants [15].  
Partitioning to biosolids during this process can give the impression of “removal” 
from final treated effluent, but since they are not degraded they may contribute to 
non-point source contamination through runoff when WWTP biosolids are 
recycled as agricultural fertilizers [16].  A number of tertiary treatments have 
shown significant increases in PPCP removal efficiency, but the cost of such 
systems has hindered their widespread implementation [17].  Therefore, PPCP’s 
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have the potential to make their way into the environment through WWTP 
effluent [18]. 
 In addition to WWTP effluent as a point source of PPCP’s, non-point 
sources may play a significant role in the introduction of PPCP’s in the 
environment.  Leachate from PPCP’s disposed of in landfills has been shown to 
be a non-point source for contamination of groundwater and receiving streams 
[19].  Application of biosolids from WWTP’s to fields as fertilizers can act as a 
source for PPCP runoff into streams [16].  Veterinary pharmaceuticals applied 
dermally can be washed off in rain events and flushed into receiving streams.  
Antibiotics and hormones that are often added to feed or injected into livestock 
can be excreted in their waste, which can eventually wash into receiving streams.  
Finally, direct application of pharmaceuticals into aquaculture water provides an 
additional route for non-point source pollution [20].   
Antidepressants in the Environment 
 Among the most commonly detected classes of PPCPs are the 
antidepressants.  Some of the antidepressants detected in environmental 
matrices include fluoxetine (Prozac®), venlafaxine (Effexor®), bupropion 
(Wellbutrin®), sertraline (Zoloft®), paroxetine (Paxil®), citalopram (Celexa®), 
fluvoxamine (Luvox®) and duloxetine (Cymbalta®).  Concentrations of these 
compounds found in aquatic matrices are typically found at ng/L concentrations 
with some reports of µg/L levels [1, 2, 6]. 
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 The relatively short half-life of most antidepressants, usually on the order 
of days [21], may decrease concern for their acute and chronic effects in the 
environment.  However, researchers have suggested that the constant addition 
of new chemical through WWTP effluent provides a consistent exposure 
sometimes referred to as “pseudo-persistent exposure”.  Antidepressants are 
one of the most commonly prescribed pharmaceutical classes [22]. 
 Of particular interest are the antidepressants fluoxetine and venlafaxine 
(physical/chemical properties in table 1.1, structures figure 1.1).  Since the 
widespread detection of pharmaceuticals began in the late 90’s, fluoxetine has 
been among the most ubiquitous PPCPs found in environmental matrices.  Some 
concentrations that have been measured include 5.5 ng/L in a Las Vegas, NV 
WWTP effluent [23], 12 ng/L in an unspecified US stream [1], and 18.7 ng/L at a 
sewage treatment plant outfall in Oslo, Norway [6].  The highest reported value in 
the literature was found in the Little River, Ontario, Canada, at 99 ng/L [4].  
 Venlafaxine has not been examined as often as fluoxetine but has been 
found at much higher concentrations.  Some concentrations reported in the 
literature include 672 ng/L downstream of a WWTP in Boulder Creek, CO, and 
690 ng/L downstream of a WWTP in Four Mile Creek, IA [24].  Venlafaxine has 
been detected in metropolitan rivers of Madrid, Spain, at median concentrations 
of 57 ng/L and 300 ng/L in WWTP effluent [25, 26].  A study reporting 
contributions of antidepressants in WWTP effluent to receiving streams reported 
venlafaxine concentrations as high as 808 ng/L in treated effluent and 901 ng/L 
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downstream of the WWTP in the Grand River, Ontario, Canada [27].  The highest 
reported values in the literature were found in wastewater effluent with 
concentrations >2 µg/L [2].  Unpublished data have shown concentrations an 
order of magnitude higher than values reported in the literature (Dr. Melissa M. 
Schultz, College of Wooster, Personal Correspondence, 2010). 
Examining the Toxicity of Antidepressants Using Traditional Methods 
Acute Toxicity 
Risk assessment of any chemical must begin with basic toxicity testing to 
find the range in which a chemical is toxic.  Acute mortality testing is often the 
first step in this process [28].  Therefore, many researchers have examined the 
acute toxicity of antidepressants to aquatic animals.   
Antidepressants such as fluoxetine, sertraline, and their metabolites have 
been shown to accumulate in the muscle, liver and brain tissue of Ictalurus 
punctatus (channel catfish), Pomoxis nigromaculatus (black crappie), and 
Lepomis macrochirus (bluegill) [29].  A number of antidepressants including 
fluoxetine, sertraline, paroxetine, bupropion, and citalopram, were measured in 
the brains of white suckers (Catostomus commersonii) in streams with 
measureable concentrations of antidepressants [24]. 
Of the antidepressants, fluoxetine (Prozac®) has been the most studied as 
it is a commonly prescribed antidepressant that has been consistently detected in 
the aquatic environment.  The 48 hour acute toxicity of fluoxetine in three 
commonly used toxicity test species (Pimephales promelas, Ceriodaphnia dubia, 
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Daphnia magna) was similar with LC50 values (median lethal concentration) 
between 234 and 820 µg/L [30].  The 7 day LC50 for the western mosquito fish, 
G. affinis, was 546 µg/L [31]. 
 Studies examining the fate of antidepressants in the environment show 
that the lipophilic nature of some of these chemicals causes them to partition to 
sediment [22, 32].  As a result researchers have examined the toxicity of 
fluoxetine to sediment dwelling organisms.  Fluoxetine was shown to have much 
higher LC50 values (15.2 mg/kg) for C. tentans, an emergent insect, than 
waterborne organisms.  The other sediment dwelling organism tested (H. azteca) 
did not show a toxic response at the highest levels tested (43 mg/kg) [33].  
Overall it appears that sediment dwelling organisms may be more resistant to 
acute toxicity of pharmaceuticals.  This could also be due to increased binding of 
fluoxetine to organic carbon in the sediment, decreasing bioavailability.   
The acute toxicity of venlafaxine has not been examined in the literature 
using traditional toxicity testing methods, however 21 day exposures of adult 
male fathead minnows to venlafaxine at environmentally relevant concentrations 
(305 and 1104 ng/L) caused ~40% mortality[34].   
Chronic Toxicity 
Though acute effects of antidepressants have been shown for both 
waterborne and sediment dwelling organisms, the concentrations used in these 
studies are orders of magnitude higher than those measured in WWTP effluent 
and their receiving waters.  As a result of the low concentrations and long 
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exposure periods likely in the environment, researchers have also examined the 
chronic effects of these chemicals on aquatic organisms.   
Fluoxetine did not cause any decreases in egg production, hatching 
success, or rate of fertilization at the highest concentration tested (5 µg/L) in 
Japanese medaka, Oryzias latipes [35].  In the presence of low concentrations of 
fluoxetine (71 µg/L) the western mosquito fish showed delayed development of 
sexual morphology [31].  Sertraline, an antidepressant with a similar mode of 
action to fluoxetine, caused decreased fecundity in C. dubia at 45 µg/L [36].     
Chronic studies have also been performed for sediment dwelling 
organisms.  Twenty eight day fluoxetine exposure at 0.94 mg/kg caused 
increased reproduction in the oligochaete, Lumbriculus variegatus, but 56 day 
fluoxetine exposures at 0.81 mg/kg caused decreases in reproduction in the mud 
snail, Potamopyrgus antipodarum [32].   
With the exception of a single study [34], the overall consensus of the 
literature is that antidepressants do not cause acute and chronic effects at 
environmentally relevant concentrations. Antidepressants are designed to alter 
behavior in humans through modulation of brain neurotransmitters [37].  The 
same neurotransmitters and biochemical pathways also exist in fish, therefore 
examination of the behavioral effects of antidepressants in fish warrants 
investigation [38]. 
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Antidepressant Mode of Action 
 Environmental contamination with antidepressants causes reason for 
concern due to the modes of action of the two antidepressants mentioned above, 
fluoxetine and venlafaxine.  The most commonly prescribed antidepressants are 
designed to alter behavior in humans through blocking the reuptake of serotonin, 
norepinephrine, and dopamine (structures in figure 1.2), monoamines thought to 
be responsible for modulating behavior.  There are many classes of these 
compounds including the selective serotonin reuptake inhibitors (SSRIs) which 
include fluoxetine (Prozac®), and sertraline (Zoloft®), the serotonin and 
norepinephrine reuptake inhibitors (SNRIs) which include venlafaxine (Effexor®), 
and the dopamine and norepinephrine reuptake inhibitors (DNRIs) which include 
bupropion (Wellbutrin®) [2].  The two chemicals that were focused on in the 
current study, fluoxetine and venlafaxine, work through blocking the reuptake of 
serotonin (SSRI) and both serotonin and norepinephrine (SNRI), respectively. 
 Neurotransmitters are responsible for transmitting electrochemical signals 
between neurons throughout the body.  Monoamines such as serotonin, 
norepinephrine, and dopamine are neurotransmitters that are released from 
synapses of the axon terminal of neurons.  These neurotransmitters are released 
into the synaptic cleft between the axon of the upstream neuron and the dendrite 
of downstream neuron where they bind to the receptors.  Activation of receptors 
on post-synaptic neurons opens ligand gated ion channels, which regulate the 
action potential, and therefore, the signal transmission in neurons.  Once signals 
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have been transmitted, neurotransmitters release from dendritic receptors and 
are either broken down by monoamine oxidases or are recycled into the 
synapses of the upstream neuron.  Recycling is accomplished through reuptake 
transporters in the cell membrane of the upstream neuron [39].   
 Fluoxetine is known as a selective serotonin reuptake inhibitor (SSRI).  It 
functions by blocking the serotonin reuptake transporter (5-HTT or SERT) on the 
synapse of the upstream neuron [37, 38].  This leaves serotonin in the synaptic 
cleft for longer, resulting in continued signal transduction.  It is thought that 
decreased levels of serotonin, as well as other neurotransmitters, released 
during neuronal signal transduction is the leading cause of many depressive 
disorders.  Administration of SSRI antidepressants allows for prolonged signal 
transduction, which is thought to decrease symptoms of many depressive 
disorders [37]. 
 Because the role of individual neurotransmitters in psychological disorders 
is not completely understood, some researchers believe that increasing signal 
transduction through multiple neurotransmitters may increase the effectiveness 
of antidepressants.  Venlafaxine is known as a serotonin and norepinephrine 
reuptake inhibitor (SNRI).  It simultaneously blocks the reuptake transporters of 
both serotonin and norepinephrine.  It is also thought to mildly inhibit the 
reuptake of dopamine [40].   
 It is important to note that upon initial administration of SSRI and SNRI 
antidepressants brain monoamine concentrations can actually decrease.  
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Mammalian literature suggests that when SSRI and SNRI antidepressants are 
bound to monoamine reuptake transporters, un-recycled monoamines can 
activate negative feedback loops that are responsible for maintenance of 
neuronal monoamine concentrations.  This is accomplished through binding of 
autoreceptors on the axon terminal of the pre-synaptic neuron.  Binding of these 
autoreceptors inhibits additional release of monoamines into the synaptic cleft.  
This feedback inhibition mechanism is thought to initially decrease monoamine 
release in turn decreasing overall monoamine concentrations.  Over time the 
auto receptors become desensitized and allow further release of monoamines, 
permitting the therapeutic function of the chemical.  This process can take 2-4 
weeks to run its course [41].   
The Role of Neurotransmitters in Behavior 
Monoamines in Humans 
 It has long been understood that neurotransmitters, especially 
monoamines, play a major role in modulation of behavior, as well as many 
physiological functions in humans.  Serotonin is thought to play a role in mood, 
behavior, appetite, and cerebral circulation. Dopamine has been implicated in 
control of motor function as well as emotional reward.  Norepinephrine is thought 
to be involved in behavioral arousal, as well as playing a major role in fight or 
flight response.  While individual monoamines have been implicated in many 
behaviors and physiological processes, it is more likely that multiple 
neurotransmitters interact to control behavior in humans [42]. 
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Monoamines in Fish 
Monoamine signal transduction is thought to be highly conserved across 
kingdoms and phyla, including fish.  Serotonin (5-hydroxytryptamine or 5-HT) has 
been implicated in partially or fully controlling a number of physiological functions 
in fish.  These include respiration, heart rate, stress response, immune response, 
reproduction and behavior [38].  The relationship between 5-HT and behavior 
has been examined extensively. 
Behaviors thought to be controlled by 5-HT include locomotion, 
aggression, feeding, migration, and social hierarchies.  The general consensus is 
that an increase in brain serotonin levels causes a decrease in overall activity.  
Increased serotonin levels have been correlated with decreased spontaneous 
locomotor activity [43]. Intracerebroventricular injections of 5-HT and 5-HT 
receptor agonists have resulted in decreased aggression and feeding [44, 45]. 
Differences in brain 5-HT over the lifespan of fish have been hypothesized to 
influence migration and smolt transformation [46].  Finally, increased 5-HT levels 
post aggressive encounter have been implicated in maintaining subordinate 
behavior in the loser of the encounter.  5-HT levels droped immediately in fish 
that won an aggressive encounter, which may help them maintain their 
dominance [47].   
Though there seems to be a general trend toward increasing 5-HT 
causing decreased aggression, feeding, and dominance, a few studies have 
found the opposite effect.  Decreased 5-HT levels resulting from exposure to 
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contaminants have caused increased time to capture prey and decreased 
appetite in fish [48, 49]. 
While measurement of 5-HT levels has been used for correlating behavior 
and brain biochemistry, some have suggested that ratios of 5-
hydroxyindoleacetic acid/5-hydroxytryptamine (5-HIAA/5-HT) may be better 
predictors of behavior.  5-HIAA is a metabolite of 5-HT and the ratio of 5-HIAA/5-
HT can give an indication of how serotonin levels are changing in the brain.  5-
HIAA/5-HT ratios have been shown to increase during food deprivation, and in 
subordinate fish when encountering dominant fish [49-51]. 
Interaction between 5-HT and other neurotransmitters also presents 
interesting questions.  Corticotropin releasing factor (CRF) has been shown to 
partially or fully reverse the inhibitory effects of serotonin on feeding behavior 
[45]. Gamma-aminobutyric acid (GABA) and dopamine may also have 
interactions with serotonin [52]. 
Norepinephrine and epinephrine have been implicated in many of the 
same physiological functions as serotonin.  These functions include, stress 
response [53], feeding [54], locomotor activity [55], social hierarchies [56], and 
migration [57].  But the body of literature is much smaller for norepinephrine and 
epinephrine, which may be because the release of these neurotransmitters is 
often controlled by serotonin [38].  Therefore the study of serotonin may be more 
important. It may also be due to the difficulty in measurement of these 
neurotransmitters. 
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The literature suggests that dopamine acts in the opposite manner of 
serotonin, with increasing dopamine causing increased aggression, locomotor 
activity, and social dominance.  The addition of dopamine agonists to water with 
tilapia increases locomotor activity while the addition of dopamine antagonists 
decreases locomotor activity [58]. Dopamine is also thought to play a role in 
cognitive learning in fish.  Zebrafish exposed to nicotine, a known dopamine 
agonist, showed increased choice accuracy performance after a training period.  
Increased accuracy was also accompanied by increased levels of DOPAC 
(dihydroxyphenylacetic acid), the primary metabolite of dopamine, indicating 
increases in dopamine levels [59].   
Research has shown that dopamine plays a major role in aggression and 
social dominance. It may act in a bimodal fashion in the brain with different 
regions showing changing patterns of dopaminergic activity under different 
scenarios.  Following aggressive social interactions dopamine was shown to 
decrease in the hippocampus of rainbow trout while increasing in the 
hypothalamus and subpallium [60].  Artic charr injected with L-dopa (precursor to 
dopamine) have shown dominance over untreated males when grouped together 
which was correlated with a dose dependent increase in both dopamine and 
DOPAC in fish brains [61].  Researchers have detected increased levels of 
homovanilic acid, another dopamine metabolite, in dominant artic charr when 
compared to their subordinate counterparts [62].  The general consensus seems 
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to be that dopamine appears to “act in a stimulatory manner on aggressive or 
competitive behavior in fish [43].” 
It is important to note that while the body of literature for monoamines and 
their effects on behavior is rather large, much of it is highly speculative.  On one 
hand there are many studies in which monoamine concentrations are measured 
and correlated with changes in behavior.  But the cause of this change in 
monoamine levels is not always clear.  For example, in the environmental 
toxicology literature, contaminants such as PCB’s, lead and mercury have been 
implicated in changing serotonin levels, and behavior [63, 64].  But the multiple 
modes of action of these environmental contaminants complicate causal 
determination between alteration in 5-HT concentrations and behavioral 
changes.  On the other hand there are studies that expose fish to monoamine 
modulators (parent monoamines, antidepressants, receptor agonist/antagonists), 
but do not measure the resulting 5-HT changes [45, 65].  It is assumed that the 
modulators will work as intended to, but a few studies have shown that may not 
be the case [44, 48].  Therefore, it is important to ensure that the modulator used 
is specific enough to ensure it is causing the behavioral effect.  This must be 
confirmed by measuring levels of the modulators target molecule to ensure it is 
working as expected. 
Ecological Relevance of Behavior 
 An organism’s ecological fitness can be considered its ability to 
successfully reproduce and contribute its genetic traits to the next generation 
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[66].  The importance of behavior in ecological fitness can be illustrated using the 
notion of scope for growth. 
Scope for growth is a concept that suggests that organisms have a finite 
amount of energy that can be expended on biological processes required for 
survival.  These can include basic physiological processes such as breathing, 
and digestion as well as outward functions required for energy collection, such as 
feeding.  Excess energy should theoretically be funneled into processes that may 
not be required for individual survival but are necessary for survival of a species.  
These include growth and reproduction.  Basic behaviors such as feeding and 
locomotion are necessary to provide sufficient energy for individual survival in 
fish.  Some species of fish also have complex reproductive behaviors that are 
performed during mate attraction.  Therefore, contaminants that affect behavior 
can directly decrease an organism’s scope for growth through decreasing energy 
uptake, as well as indirectly, by affecting behaviors that may be necessary for 
reproduction.  Reproductive behavioral effects may be sex specific as male fish 
allocate more of their excess energy into reproductive behaviors and secondary 
sex characteristics while females divert excess energy into egg production [67].  
Either route can affect an organism’s contribution to the next generation, which 
can ultimately cause effects to the population as a whole [68-70].  
Behavioral Endpoints in Toxicity Testing 
Concentrations of antidepressants required to cause acute and chronic 
effects (especially mortality) in aquatic organisms are typically much higher than 
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concentrations found in environmental matrices [1, 23].  Therefore, researchers 
have begun using non-traditional endpoints that may be more sensitive indicators 
of antidepressant toxicity.  Behavioral endpoints are among the tools being 
utilized to examine these trace contaminants [48, 71, 72]. 
Animal behavior has been studied for many years but is underutilized in 
toxicity testing.  Behavioral testing can be problematic because animal behavior 
is often relatively complex, exhibits high variability, and testing behavior requires 
more time than traditional acute and chronic toxicity testing.  But when designed 
and performed correctly, behavioral endpoints can be more sensitive than 
traditional endpoints and can be extrapolated to the population level [73]. 
The use of behavioral assays in toxicity testing began during the early 80s 
with studies using behavior to assess the chronic toxicity of chemicals.  A study 
examining the use of behavioral endpoints as indicators of mode of action 
suggested a number of endpoints that could be used in toxicity testing included 
schooling behavior, swimming performance, and reproductive behavior [74].  
Their analysis indicated that schooling behavior seems to be the most sensitive 
indicator of chronic toxicity.  The use of swimming capacity and swimming activity 
as a measurement of sublethal toxicity in fishes has been examined.  Swimming 
capacity is a measure of a fish’s orientation and ability to swim against flow.  A 
number of variables can be measured in an attempt to quantitate swimming 
activity including of the frequency and duration of movements, speed and 
distance traveled during movements, frequency and angles of turns, position in 
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the water column and form and pattern of swimming.  It was found that swimming 
capacity is very inconsistent and often coincides with mortality.  Swimming 
activity on the other hand is much more consistent in identifying chronic toxicity, 
and is also more sensitive to lower concentrations of toxicants [75]. Pesticides 
have been shown to increase optomotor response (movement towards reference 
points within a fish’s field of vision) as a result of an artificial cue.  But pesticide 
exposure also decreased swimming capacity [76].  Because swimming and 
schooling behaviors can be variable and hard to interpret, the use of high speed 
video and tracking software has been suggested as methods for standardization 
of these behaviors [73]. 
Foraging behavior has also been suggested as a possible indicator of 
chronic toxicity.  Studies have focused on the ability of prey to avoid capture or 
the reduction of feeding success either by loss of appetite or predation ability.  
There do seem to be apparent problems with using these behaviors to quantify 
chronic toxicity as they often involve qualitative observations that are not easy to 
quantify [77].  The use of high speed video has allowed for quantifiable changes 
in predator avoidance to be recorded.  Exposure to estrone as embryos can 
cause decreases in startle response in fathead minnows.  Exposure to 17β-
estradiol for 12 days post hatch also adversely effected fish startle responses 
[78].  It has been suggested that using time to eat as well multiple foraging 
models can be used to quantify changes in predation behavior as an indicator of 
sublethal toxicity [48, 77, 79]. 
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Reproductive behavior has also been used as a behavioral endpoint in 
toxicity testing.  The courtship and reproductive behaviors of many fish species 
including the three spine stickleback, fathead minnow, mollies, and guppies, 
have been described in the literature.  Deviations from known behaviors have 
been suggested as a potential sublethal toxicity endpoint [80].  Male fathead 
minnow reproductive behavior is a popular endpoint in behavioral toxicity testing.  
Larval exposures to lead caused significant decreases in nest guarding and 
maintenance ability once the fish reach sexual maturity [81].  Exposure to 
ethinylestradiol has been shown to cause decreased aggression and ultimately 
subordination to unexposed male fathead minnows [82].  Exposure to 
nonylphenol can either increase or decrease male fathead minnow nest guarding 
aggression depending on dose [83].   
Antidepressant Behavioral Toxicity Testing 
Antidepressants were designed to alter behavior in humans through 
modulation of neurotransmitters in the brain.  It has been shown that the same 
neurotransmitters exist in fish and also influence behavior in fish [43, 44, 57, 84, 
85].  Therefore, it is reasonable to believe that low level exposure to 
antidepressants could also cause behavioral alterations in fish.   
Though the effect of antidepressants on fish behavior has been relatively 
understudied, some aspects have been examined.    Fathead minnow embryos 
and larvae exposed to the SNRI venlafaxine showed increased startle response 
latency periods.  Embryonic fathead minnows exposed to environmentally 
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relevant concentrations of the SSRI fluoxetine exhibited decreased escape 
velocity after a stimulus, while larval exposures to bupropion, a DNRI, also 
decreased escape velocity.  Exposures to environmentally relevant doses of 
fluoxetine and venlafaxine caused reduced total escape response, a combination 
of latency and escape velocity.  Finally, exposure of fathead minnow embryos 
and larvae to mixtures of fluoxetine, venlafaxine, sertraline, and bupropion 
caused decreased escape velocity as well as reduced total escape response in 
exposed larvae [72].      
Adult male fathead minnows exposed to environmentally relevant 
concentrations of the antidepressants sertraline, fluoxetine, bupropion, and 
venlafaxine did not exhibit changes in nest guarding behavior when challenged 
with an unexposed male.  Mixtures of these compounds also exhibited no effect 
[34].  
Gulf toadfish, Opsanus beta, injected with fluoxetine showed increased 
plasma serotonin levels which coincided with increased aggressive behaviors 
from dominant individual fish when interacting with other individuals [86].  
Gammarus pulex exposed to environmentally relevant concentrations of 
fluoxetine (10-100 ng/L) exhibited decreased activity when compared to controls.  
No effects were seen at levels in the part per billion range [71]. 
A predator prey bioassay that was previously designed in our lab has 
been used to determine the effect of antidepressants on fish brain biochemistry 
and predatory behavior.  The predator (hybrid striped bass) was challenged with 
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a contaminant over a period of time.  Periodically (every three days) during the 
challenge period the predator was given the opportunity to feed on minnows.  
The amount of time to capture each minnow was quantified and compared 
among treatments to determine if the contaminant had a significant effect on 
predation behavior [48, 79]. 
When bass were exposed to fluoxetine (Prozac), a SSRI, for six days, 
they exhibited increased time to capture prey. This increase was correlated with 
decreased brain serotonin levels.  However it is important to note that 
concentrations necessary to cause this effect (~35 µg/L) were 20 times less than 
reported 48hrLC50 values but three orders of magnitude higher than measured 
environmental concentrations [48].  Bass were able to recover, and resume 
normal feeding behavior after a six day depuration period [48].  Longer 
exposures (27 days) of bass to fluoxetine at environmentally relevant 
concentrations of 0.1 µg/L to 10 µg/L caused no change in predation behavior or 
brain chemistry [87]. 
Dissertation Goals 
    Building from previous work completed in our laboratory using the 
predatory bioassay described above, the goal of this dissertation was two-fold. 
First, to increase understanding of the roles neurotransmitters play in controlling 
behavior in fish.  By using antidepressants as neurotransmitter modulators I 
hoped to correlate feeding behavior with changes in brain chemistry.  Second, to 
determine if antidepressants with different modes of action found in aquatic 
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environments can cause effects on fish predation behavior and brain chemistry, 
whether exposed individually, or in mixtures.  I hypothesized that exposure to 
fluoxetine, venlafaxine, and mixtures of the two will decrease brain 
neurotransmitters which will result in increased time to capture prey.  I tested this 
hypothesis through the following objectives: 
1. Determine the threshold of effect in hybrid striped bass predation behavior 
during long term fluoxetine exposure.  
2. Determine the effects of the SNRI antidepressant venlafaxine on the brain 
biochemistry and predation behavior of hybrid striped bass 
3. Determine the effects of mixtures of fluoxetine and venlafaxine on brain 
biochemistry and predation behavior in hybrid striped bass. 
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                      Fluoxetine                                       Venlafaxine 
Figure 1.1: Structures of the antidepressants fluoxetine and venlafaxine 
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            Serotonin                     Norepinephrine                       Dopamine 
 
Figure 1.2 Structures of the neurotransmitters serotonin, norepinephrine, 
and dopamine
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Table 1.1: Physical-chemical properties of fluoxetine and venlafaxine 
Compound 
Molecular  
weight 
(g/mol) 
Empirical  
formula log Kow 
Solubility 
in  
water 
(mg/L) 
Vapor  
pressure  
(mm Hg) 
Henry's law  
constant  
(atm m3/mol) pKa 
Fluoxetine 309.33[88] C17H18F3NO[88] 4.05[32] 38[32] 8.9x10
-7[32] 8.9 × 10−8[89] 10.06[30] 
Venlafaxine 277.4[88] C17H27NO2[88] 3.28[90] 270[90] 4.92x10
-7[91]  2.04x10-11[90] 9.4[92] 
 
  
Note: Brackets accompanying values are references for each number.   
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CHAPTER TWO:  
THRESHOLD OF EFFECT FOR 27 DAY FLUOXETINE EXPOSURE ON 
HYBRID STRIPED BASS PREDATION BEHAVIOR 
Introduction 
 In recent years fluoxetine, an antidepressant marketed under the trade 
name of fluoxetine, has become an environmental concern due to its detection in 
aquatic matrices [1, 2].  Concentrations as high as 99 ng/L have been detected in 
wastewater effluent [3].   
 Traditional acute and chronic toxicity tests have shown that exposure to 
fluoxetine at environmentally relevant concentrations does not result in mortality. 
The 48 hr. LC50 for larval fathead minnows (Pimephales promelas) was 705 µg/L 
and 820 µg/L for Daphnia magna [4].   But the unique mode of action of 
fluoxetine suggests that traditional toxicity tests may not be the most appropriate 
method to measure toxicity.   
Fluoxetine belongs to the selective serotonin reuptake inhibitor (SSRI) 
class of antidepressants, which works through inhibition of serotonin recycling 
during neuronal signal transmission [5, 6].  The serotonergic system is thought to 
be highly conserved across animal phyla and kingdoms, including fish [6].  
Serotonin has been implicated in the control of numerous behaviors in fish 
including locomotion [7], aggression [8], feeding [9], migration [10], and social 
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hierarchies [11].  Modulation of serotonin by the SSRI antidepressant fluoxetine 
may impact a number of behaviors but examination of behavioral effects in fish is 
fairly limited. 
Fluoxetine has been implicated in reduced escape response, a measure 
of predator avoidance, in larval fathead minnows [12].  Gulf toadfish injected with 
fluoxetine exhibited increased aggression, which coincided with increased 
plasma serotonin levels [13].  Intraperitoneal injections of fluoxetine have been 
shown to cause decreased aggression in bluehead wrasse (Thalassoma 
bifasciatum) [14]. 
 Using an assay designed in our laboratory, the effect of fluoxetine on fish 
predatory behavior has been examined.  Hybrid striped bass exposed to 
fluoxetine for six days took longer to capture their prey when compared to 
controls.  The increase in time to capture prey was correlated with decreased 
serotonin levels in the brains of exposed bass [15].  This result is contradictory to 
the expected effect of fluoxetine, which is designed to increase levels of 
serotonin in the brain.   
In mammalian literature, it has been shown that initial administration of 
SSRI antidepressants can cause decreased brain serotonin levels.  One possible 
explanation for this is that serotonin acts as its own feedback inhibitor.  
Autoreceptors (5-HT1A) on presynaptic neurons bind serotonin in the synaptic 
cleft.  When binding sites are saturated, further release of serotonin ceases.  
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Normally, serotonin left in the synaptic cleft is either broken down or taken back 
into the pre-synaptic neuron to be re-used.  But because re-uptake is blocked by 
the SSRI antidepressant, serotonin remains in the cleft where it can continue to 
bind autoreceptors and prevent the further release of serotonin.  It is believed 
that over time these autoreceptors become desensitized to excess serotonin in 
the cleft and allow serotonin to once again be released.  But this process can 
take 2 to 4 weeks to complete, which may explain the decreased serotonin levels 
after 6 day exposures [16].   
To test if this phenomenon exists in fish, hybrid striped bass were exposed 
to fluoxetine for a period of 27 days [17].  Because the lowest concentration 
tested in the initial study (23 µg/L) [15] was approximately two orders of 
magnitude higher than concentrations measured in waste water treatment plant 
(WWTP) effluent [18], concentrations closer to the WWTP effluent studies were 
used.    Results from the 27 day indicated that exposures to 0.1, 1, and 10 µg/L 
for 27 days did not have a significant effect on hybrid striped bass predatory 
behavior.  There was also no effect on brain serotonin levels in the exposed bass 
[17]. 
Short term (six day) exposures to fluoxetine caused increased time to 
capture prey at concentrations as low as 35 µg/L [15] while 27 day exposures at 
concentrations up to 10 µg/L [17] did not cause any effects.  The difference in 
behavioral toxicity between these studies raises questions about whether 
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increased exposure duration can increase the effective concentration of 
fluoxetine. Therefore, the first objective of my dissertation research was to 
determine what the threshold of effect was for long term fluoxetine exposure.  I 
hypothesized that 27 day exposures to fluoxetine (10-40 µg/L) will cause an initial 
dose dependent increase in time to capture prey.  Though brain biochemistry 
was not measured in the current study, I hypothesized that as autoreceptors 
become desensitized to the presence of fluoxetine in synaptic clefts, I would see 
a recovery of ability to capture prey. 
Materials and Methods 
Test Chemicals 
 Fluoxetine hydrochloride was generously donated by Fermion (Finland).  
HPLC grade methanol, acetone, acetonitrile, glacial acetic acid, and triethylamine 
were purchased from Fisher Scientific (Pittsburgh, PA, USA).  Trace metal grade 
concentrated hydrochloric acid was purchased from Spectrum Chemicals 
(Gardena, CA, USA).  Water used for analytical procedures was ultra-purified 
using a Milli-Q Super-Q Filtration system (Millipore™, Billerica, MA, USA) with a 
measured resistivity of 18.2 MΩ·cm.  
Fish 
 Hybrid striped bass (Morone saxatilis x M. chrysops) were generously 
donated from Southland Fisheries (Columbia, SC, USA) as fingerlings.   Fish 
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were held in 450 L circular holding tanks in the cherry farm aquatic research lab 
at Clemson University (Clemson, SC, USA).  Holding tanks were maintained as 
flow through systems, constantly supplied with fresh water from Lake Hartwell 
(Clemson, SC, USA).  Before reaching holding systems, water was filtered 
through a gravel bed, and sterilized with UV radiation.  Water temperature was 
maintained between 22 and 25°C using a mixture of a mbient and heated (via 
inline heater) or chilled water (via inline chiller), depending on incoming water 
temperature.  Water was constantly aerated with air stones and agitators 
(Boatcycle Inc., Henderson, TX, USA).  During holding, bass were fed a 
commercial diet (Finfish Silver 4.5 mm slow sink) purchased from Zeigler Bros, 
Inc. (Gardners, PA, USA). 
 Fathead minnows were purchased from Anderson Minnow Farm (Lonoke, 
AR, USA).  Minnows were held in 100 L holding tanks using the same water as 
described above.  During holding times, minnows were fed a commercial diet 
(Tetramin® Tropical Flakes) purchased from Dr’s Foster and Smith, Inc. 
(Rhinelander WI, USA). 
Bass Group Training 
Because bass were grown on a pelleted feed, conditioning to live diet was 
required before the initiation of behavioral assays.   Hybrid striped bass (mass: 
174.54g ± 45.91, length: 212.97mm ± 20.68) were randomly removed from 
holding tanks and placed into a separate 300 L rectangular holding tank for group 
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training.  Water conditions in the group holding tank were the same as holding 
tanks.  Bass were starved for three days prior to the start of group training.  On 
day zero of training, bass were fed four minnows/bass in the group training tank.  
Bass were fed an additional four minnows/bass on day three and day six. 
Experimental Design 
 Hybrid striped bass were exposed to fluoxetine in a static exposure 
scenario with renewals on days 6, 12, 18, and 24.  Exposures took place in 113 
liter aquaria measuring 92.1 x 32.4 x 40 cm purchased from Deep Sea Aquatics 
(Garland, TX, USA).  Volumes of 80 and 40 liters were measured and marked on 
each tank for measurement of exposure volume and half renewal volume, 
respectively.  Each tank had a 1.9 cm PVC vertical standpipe drilled into the front 
panel for control of water volume when maintained as a flow through.   
Water for exposure tanks was taken from Lake Hartwell (Clemson, SC, 
USA) (pH = 6.28 ± 0.17, hardness 24 mg/L as CaCO3, alkalinity 10 mg/L as 
CaCO3).  Before entering the laboratory, water was filtered through a gravel bed 
and UV sterilized.  Temperature was maintained via a mixing valve (M & M 
Control Services, Grayslake, IL, USA) combining ambient water with either 
chilled (via inline chiller) or heated (via inline water heater) water, depending on 
the temperature of lake water.  Water was then passed through a multi-resin 
filtration system (Water and Power Technologies, Columbia, SC, USA) for 
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additional cleanup and dispensed into tanks.  Each tank was constantly aerated 
via air stones and covered with two square grated covers. 
Hybrid striped bass were removed from the group training tank and placed 
into individual aquaria (one bass/tank).  Bass were allowed to acclimate to the 
aquaria for nine days.  During the acclimation period, bass were fed four fathead 
minnows (~4 cm long) on days three and six.  The time to capture each minnow 
was recorded for selection of fish for exposures.   
Three days after the final individual training (day zero of exposure) the first 
feeding event was quantified before the addition of fluoxetine.  Before each 
feeding event, half of the tank cover and the air stones were removed from each 
tank and fish were allowed five minutes to adjust.  Four fathead minnows (~4 cm 
long) were dropped into tanks, and bass were allowed 25 minutes to consume all 
minnows.  The time bass took to capture each minnow was recorded.  Any 
minnows not consumed during the 25 minute feeding period were removed, and 
a time to capture of 1500 seconds (25 minutes) was assigned for each 
unconsumed minnow.  Air stones and covers were replaced following the feeding 
event.  Only bass that consumed at least three minnows during the day 0 feeding 
event, and exhibited comparable feeding during the previous individual training 
days were selected for inclusion in the test.  Following the feeding event, 
incoming water was shut off and all tanks were set to the final test volume of 80 
L.  Tanks were then randomized, assigned treatments (one bass per replicate 
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tanks/five replicates per treatment), and spiked with appropriate volumes of 
fluoxetine to reach nominal concentrations.  Concentrations tested were 0, 10, 
20, 30, and 40 µg/L.   
 Additional feeding events took place on days 3, 6, 9, 12, 15, 18, 21, 24, 
and 27.  Water quality (pH, D.O. temperature) was measured during each 
feeding event using a Fisher Scientific Accumet AP84 pH/dissolved oxygen 
meter (Fisher Scientific, Pittsburgh, PA, USA).  During the exposure, five 
replicate bass were removed from each treatment after each feeding event and 
euthanized for collection of brain tissue.  Because the number of exposure tanks 
was limited, four tests were conducted in series (27, 18, 12, and 6 days) to 
produce sufficient replicates for tissue collection.     
Fluoxetine Exposures 
Stock solutions of fluoxetine were prepared by dissolving fluoxetine HCl in 
methanol.  Concentrations of stock solutions were selected to ensure <0.1 mg/L 
methanol in exposure tanks, the ASTM recommendation for methanol as a 
carrier solvent (ASTM E1241-92).  Spiking solutions were prepared by adding 
equivalent volumes of fluoxetine stock to 1 liter of milli-Q water.  Equivalent 
volumes of the spiking solutions were added to tanks to reach nominal 
concentrations.  Total methanol concentrations for the highest treatment were 
calculated and control tanks were spiked with equivalent amounts to ensure 
there was no carrier solvent toxicity.  Because of the low concentration of 
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fluoxetine in exposure tanks, spiking solutions were measured to confirm 
concentrations.  One liter of spiking solution was sufficient for spiking tanks and 
extraction for measurement on HPLC with a fluorescence detector.  Nominal 
concentrations selected for the test were 0, 10, 20, 30, and 40 µg/L.  Stock and 
spiking solutions were prepared daily. 
The half-life of fluoxetine was previously determined to be approximately 
three days in our system [17].  To maintain relatively constant concentrations 
throughout the exposure, tanks were re-spiked on days 3, 9, 15, and 21 with 
equivalent volumes of spiking solutions to reach nominal concentrations.  To 
prevent buildup of nitrogenous waste products, tanks were renewed on days 6, 
12, 18, and 24.  Renewals were performed following the feeding event of the day 
by removing half the volume from the tank (~40L) and replacing with fresh water.  
Tanks were re-spiked with appropriate volumes of spiking solution taking into 
account the three day half-life and the volume removed from the tank. 
Fluoxetine Analysis 
 The low concentrations of fluoxetine made it impractical to measure 
fluoxetine concentrations in individual exposure tanks.  Therefore, concentrations 
of spiking solutions were measured to confirm concentrations.  Measured 
volumes of spiking solutions were adjusted to a pH of approximately three with 
concentrated hydrochloric acid.  Samples were extracted on 6 ml C-18 solid 
phase extraction cartridges with a bed weight of 500 mg (HyperSep C18 SPE 
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cartridge, Thermo Fisher Scientific, Pittsburgh, PA, USA).  Prior to extraction, 
cartridges were equilibrated with 6 ml of acetone, 6 ml methanol, and 6 ml milli-q 
water.  Samples were loaded onto the cartridges and allowed to dry under 
vacuum. Cartridges were stored at -20°C until eluti on and analysis.   
 Cartridges were eluted with methanol/1% acetic acid and stored in 
sample vials for HPLC analysis.  The HPLC consisted of a Waters 1525 Breeze 
HPLC Pump with a Water 717 Plus auto sampler and a Waters 2475 multi 
wavelength fluorescence detector (Waters, Milford, MA, USA).   The mobile 
phase consisted of 40 parts HPLC grade acetonitrile: 60 parts milli-Q water, pH 
adjusted to 3.0 with glacial acetic acid: 4 parts triethylamine. The mobile phase 
was filtered through a 0.2 µm nylon filter and degassed using a sonication bath.  
The flow rate was set at 1 ml/min and a 40 µl injection volume was used.  A 
Varian Polaris C-18A reverse phase analytical column (250 mm long, 4.6 mm 
I.D.) was used to achieve chromatographic separation.  The fluorescence 
detector was set at excitation wavelength 270nm and emission wavelength 
300nm.  Run times were approximately 6 minutes per sample.   
Data Analysis 
Time to capture prey was analyzed using Statistical Analysis Software 9.2 
(SAS, Cary, NC, USA).  A general linear means for mixture distributions (PROC 
GLIMMIX) procedure was used to perform a two factor ANOVA utilizing 
treatment and day as independent variables and tank as a random variable.  The 
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time to capture prey data were non-normally distributed with non-homogenous 
variances.  The GLIMMIX procedure uses an analysis matrix that accounts for 
non-normal distribution and non-homogenous variances in data points.   Least 
squared means was used to perform multiple pairwise comparisons of data and 
differentiate statistical differences across and within treatment, day, and 
treatment by day interactions. 
Results 
Water Quality Measurements 
Water quality measurements were averaged (mean ± standard deviation) 
for the entire test.  pH, dissolved oxygen, and temperature were 6.16 ± 0.54, 8.18 
mg/L ± 3.54, and 20.75°C ± 1.29, respectively. 
Fluoxetine Concentrations 
 Measured fluoxetine spiking stock concentrations were used to calculate 
treatment concentrations.  The average concentration (mean ± standard 
deviation) over the entire test for 10, 20, 30, and 40 µg/L treatments were 9.95 ± 
1.50, 18.59 ± 3.51, 27.42 ± 3.19, and 41.17 ± 5.51 µg/L, respectively. 
Behavioral Assays 
 Complete numerical results from behavioral assays are presented in Table 
A-1 of the appendix.  The times for hybrid striped bass to capture their first prey 
throughout 27 day exposures to fluoxetine are presented in Figure 2.1.  There 
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was a statistically significant increase (p<0.05) in the time to capture prey 1 for 
the bass exposed to 40 µg/L fluoxetine from day six through day 27 with the 
exception of day 21.  There was a statistically significant increase in time to 
capture prey one for the 30 µg/L treatments on day six and day 12.  There was a 
statistically significant increase in time to capture prey one for the 20 µg/L 
treatment on days 12, 24, and 27.  Because the only treatment that showed a 
consistent significant increase in time to capture prey one was the 40 µg/L 
treatments, Figure 2.2 shows time to capture prey for the 0 and 40 µg/L 
treatments with ± 1 standard error. 
 The time for hybrid striped bass exposed to fluoxetine for 27 days to 
capture their second prey is presented in Figure 2.3.  There was a statistically 
significant increase for the 40 µg/L treatments on days nine through 27 when 
compared to controls, with the exception of day 18.  Because there were no other 
significant increases for any of the other treatments, the time to capture prey two 
for the controls and 40 µg/L treatments alone are presented in Figure 2.4 with ± 1 
standard error. 
 The time for hybrid striped bass exposed to fluoxetine for 27 days to 
capture their third prey are presented in Figure 2.5.  There was a statistically 
significant increase for the 40 µg/L treatment starting on day three through day 
27 when compared to controls.  The 30 µg/L treatment showed significant 
increases on days six and twelve.  The 20 µg/L treatment showed significant 
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increases days 21 and 27.  Once again, because the 40 µg/L treatment was the 
only concentration that showed consistent significant increases over controls, the 
time to capture prey three for controls and 40 µg/L treatments alone are 
presented in Figure 2.6 with ± 1 standard error.  
The time to capture prey 4 data are not presented graphically as they 
were highly variable for both treatments and controls.  Therefore, there were not 
statistically significant treatments when compared to controls.  
In general, the data indicate that only the 40 µg/L treatment had a 
significant effect on hybrid striped bass predatory behavior.  Though there were a 
few significant data points for the other treatments on various days for various 
prey, there was no trend for these treatments.  Significance in these treatments 
could usually be attributed to high variability for that day that would usually return 
to control levels by the following observation period.  The 40 µg/L treatments 
showed significant increases in time to capture prey starting on day three (prey 
three) and continuing to day 27 (prey 1,2, and 3).  For the 40 µg/L treatment, the 
time to capture prey one and two was not significant on day 21 and day 18, 
respectively.  While these data points could indicate acclimation to fluoxetine, the 
data for the observations following these data points were significantly different, 
indicating that this is probably not the case.  These data points are still elevated 
over the controls, and increased variability in either the controls or 40 µg/L 
treatments on these days probably led to their being not significant.   
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Qualitative Behavioral Observations 
In addition to our quantitative behavioral measurements we also noted a 
number a qualitative behavioral changes in the 40 µg/L treatments. These 
observations were not compared between treatments as they were not scored 
quantitatively.  Some of the observations included spitting out prey fish, trouble 
swallowing prey, maintaining a vertical position in the water column, erratic 
swimming, swimming with dorsal surface out of the water, and regurgitation of 
digested fish. 
Discussion 
 Use of selective serotonin reuptake inhibitors, like fluoxetine, is increasing 
on a daily basis [19].  As a result, researchers have found detectable 
concentrations of these chemicals in the environment [1-3, 18, 20].  The pseudo-
persistent nature of these chemicals in the environment warrants investigation of 
the risk they pose to aquatic organisms [21].  Though SSRIs do not appear to be 
acutely and chronically toxic at environmentally measured concentrations, 
traditional toxicity tests may not capture the subtle effects these chemicals may 
have on behavior [4, 22-24]. The mode of action of these chemicals may directly 
affect behavior through modulation of serotonin in fish [12].  Serotonin has 
previously been implicated in a number of behaviors in fish, and behavior plays 
an important role in the success or failure of populations of fish [8, 9, 11, 25].   
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 A previous study [15] using the same assay as the current study showed 
that short term exposures to fluoxetine (six days) at concentrations of 23 µg/L 
caused increased time to capture prey in hybrid striped bass, a measure of 
predation behavior.  Time to capture prey also increased in a dose dependent 
manner with increasing fluoxetine concentrations (51 and 100 µg/L).  Gaworecki 
and Klaine 2008 [15] used concentrations that were two orders of magnitude 
higher than environmentally measured concentrations.  Long term (27 day) 
exposure to fluoxetine at environmentally relevant concentrations (0.1-10 µg/L) 
did not have an effect on hybrid striped bass predation behavior [17].   
The aim of the current study was to determine the threshold of effect for 
long term fluoxetine exposure.  Though fluoxetine does not have an effect on 
predation behavior at environmentally relevant concentrations, it is important to 
know the threshold of effect for risk assessments.   
Results from this study indicated that only the 40 µg/L (41.17 ± 5.51 µg/L 
measured) treatment caused consistently significant increases in time to capture 
prey in hybrid striped bass.  While some of the other treatments caused 
significant increases on random days for random prey, there was no consistent 
trend for these treatments.  Variability in response to antidepressants in 
mammals is well documented with differences in cellular receptor expression 
levels being hypothesized as the culprit [26].  Therefore, it is possible that at 
concentrations lower than 40 µg/L fluoxetine are unable to overcome the 
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individual variability of response in hybrid striped bass, which is why we saw 
various significant data point throughout exposures.  
It is also possible that fluoxetine’s effect on appetite may have played a 
role in the inconsistent effect on time to capture prey for lower concentrations 
seen in this study.  Examination of the time to capture prey one and three for the 
30 µg/L treatment shows a significant increase when compared to controls on 
day six followed by a decrease back to control levels on day nine.  A similar trend 
is seen on day 12 and 15.  This could indicate that consumption of prey on day 
three in addition to fluoxetine’s effect on serotonin may have satiated the appetite 
of 30 µg/L treated fish.  Therefore, there was a significant increase in the time 
capture prey on day six.  Fish were hungry again by day nine but satiated on day 
12 so time to capture prey was significantly increased when compared to 
controls.  SSRI antidepressants like fluoxetine have been suggested as appetite 
suppressants in mammals [27].  Serotonin has also been shown to be involved in 
gut motility in teleost fishes [28].  Therefore, this sigmoidal response may be due 
to appetite modulation by fluoxetine through serotonin.  
Time to capture prey four data were not presented graphically because 
there were no significant differences between treatments and controls for this 
prey.  Consumption of a fourth prey was highly variable for all treatments and 
controls indicating that three prey was enough to satiate some bass during 
exposure periods which may be a limitation in our experimental design. 
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Results from the current study correlate well with 6 day exposure 
concentration data previously reported from our laboratory [15].  Similar nominal 
concentrations, 40 µg/L in the current study, 35 µg/L in the six day study, caused 
a comparable effect on time to capture prey in hybrid striped bass.  The onset of 
effects was also similar, because effects on time to capture prey one was not 
seen until day six of exposure, while effects on second and third prey were seen 
as early as day three.  This may indicate that fluoxetine may have an initial effect 
on appetite with longer term exposure having effects on motor function.  
Serotonin has been implicated in controlling appetite [9] and locomotion [7] in 
fish.  In addition to quantitative behavioral measurements there were a number of 
qualitative behavior observations at our highest concentration tested that 
coincided with findings in our previous studies including maintaining a vertical 
position in the water column and swimming with dorsal surfaces out of the water 
[15]. Similar effects were noted in mosquitofish (Gambusia affinis) exposed to 
fluoxetine including changing position in the water column (associating closely 
with the surface), and swimming on their sides [22].  These qualitative behavioral 
observations are important because they are behaviors that could result in 
increased predation susceptibility in the environment, something that would not 
be captured in traditional mortality based toxicity assays. 
The dose dependent manner by which fluoxetine caused increasing 
effects on hybrid striped bass feeding behavior in our previous study [15] led us 
to hypothesize that we may see a dose dependent response to fluoxetine 
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exposure from 10-40 µg/L.  But the results show that only the 40 µg/L treatments 
caused a consistent increase in time to capture prey.  This indicates that there is 
a threshold of effect around 35 – 40 µg/L fluoxetine on the predation behavior of 
hybrid striped bass regardless of exposure duration.    A study examining the 
behavioral effects of diazinon, an organophosphorus pesticide that acts on the 
neurotransmitter acetylcholine, showed a significant increase in time to capture 
prey in hybrid striped bass at 64 µg/L and 101 µg/L.  This increase corresponded 
with a threshold decrease in brain acetylcholine esterase activity.  But there was 
not a dose dependent increase in time to capture prey in Gaworecki et al. 2009 
[29] once the threshold was reached.  This is unlike our short and long term 
fluoxetine results, which indicate that effects will continue to increase in a dose 
dependent manner once the effective threshold is reached [15].  
While the current study cannot be considered a chronic test by traditional 
standards, it does constitute a longer term exposure than most studies 
conducted with fluoxetine.  Studies that have examined the chronic effects of 
fluoxetine in fish have found that acute exposure to fluoxetine may be sufficient 
to determine the effective concentration.  The acute toxicity of fluoxetine to the 
western mosquito fish was 546 µg/L.  But chronic exposure of the same fish at 
lower concentrations 0.05-5 µg/L did not produce any quantifiable effects [22].  
Japanese medaka exposed to fluoxetine for four weeks did not show any effects 
on egg production, hatching success, or rate of fertilization at the highest 
concentration tested (5 µg/L) [30].  The results of the current study also indicate 
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the 6 day exposures to fluoxetine are sufficient to determine its effective 
concentration, and that longer term exposures do not produce toxicity at lower 
concentrations.   
Results from our previous 6 day fluoxetine study indicated a dose 
dependent decrease in brain serotonin level in fish exposed to fluoxetine.  This 
decrease was correlated with increased time to capture prey [15].  The expected 
therapeutic effect of SSRIs like fluoxetine is increased serotonin levels.  While 
this presents an apparent contradiction, investigation of mammalian literature 
reveals that delayed onset of therapeutic effects of SSRIs may be due to 
autoreceptor modulation of serotonin levels.  The binding and deactivation of 
serotonin reuptake transporters (5-HTT) by SSRIs cause increased residence of 
serotonin in synaptic cleft.  But autoreceptors on pre-synaptic axon terminal can 
regulate the further release of serotonin from the axon.  The increased residence 
time of serotonin in the synaptic cleft results in binding to autoreceptors halting 
the release of additional serotonin.  This can result in a decrease in serotonin 
levels upon initial administration of SSRIs.   Continuous administration of SSRIs 
can result in the eventual desensitizing of autoreceptors, causing an increase in 
serotonin release.  This process can take up to four weeks to complete [16].  
Therefore, the dose dependent decrease in brain serotonin levels seen during 6 
day exposures in our previous study can be expected.   
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We hypothesized that a four week exposure may cause serotonin levels to 
eventually increase due to autoreceptors becoming desensitized to fluoxetine 
exposures.  If serotonin levels did increase we may expect a recovery of ability to 
capture prey as serotonin levels reach equilibrium or increase over controls.  
Results of the current study do not indicate fish were able to recover the ability to 
capture prey over long term exposure.  We did find that there was not a 
significant difference in the time to capture prey one on day 21 and time to 
capture prey two on day 18, which may indicate potential recovery.  But time to 
capture prey levels were significantly increased on the following observation 
period in both instances.  This may indicate that time to capture prey not being 
significant on days 21 and 18 for prey one and two, respectively may have been 
be due to high individual variability on these days.  Unfortunately, brain serotonin 
levels were not measured during the current study, therefore we can only 
speculate about how serotonin is behaving in the brain.   
When comparing the results of the current study to the effects of fluoxetine 
on other behaviors, we find that our predation bioassay is slightly less sensitive 
when compared to smaller organisms.   Exposure of embryonic fathead minnows 
to environmentally relevant concentrations of fluoxetine (100 ng/L) caused 
decreased escape velocity and total escape response [12].  Gammarus pulex 
exposed to the same concentrations exhibited decreased activity when 
compared to controls [31].  But exposure of adult fathead minnows to 
environmentally relevant concentrations of fluoxetine does not cause an effect on 
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male reproductive behavior [21].  While the concentration required to cause 
behavioral effects in our assay may be higher than those required to cause 
behavioral effects in prey species like minnows, they are still two orders of 
magnitude lower than LC50 values from traditional toxicity tests.  It is also 
important to understand what levels cause effects in larger predators.  Use of 
larger organisms also allows for more tissue for biochemical and molecular 
analyses. 
Conclusions 
 Only the 40 µg/L treatment caused consistently significant effects on 
predation behavior during 27 day exposures to fluoxetine.  These results are 
consistent with our previous findings that 35 µg/L causes increased time to 
capture prey during six day exposures [15].  This indicates that 35-40 µg/L 
fluoxetine is the threshold of effect for predation behavior in this species, 
regardless of exposure duration.  Finally, results show that six day exposures 
may be sufficient for testing the effects of antidepressants on predation behavior. 
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Figure 2.1: Time to capture prey 1 for 27 day fluoxetine exposures. 
Time to capture prey one for hybrid striped bass exposed to fluoxetine for 27 days.  Treatments were 0, 10, 20, 30 
and 40 µg/L.  Asterisks represent statistical significance when compared to control. 
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Figure 2.2: Time to capture prey 1 for control and 40 µg/L treatments only. 
Time to capture prey one for hybrid striped bass exposed to fluoxetine for 27 days.  Only control and 40 µg/L 
treatments are displayed as the 40 µg/L treatment was the only concentration to show consistently significant 
increases in time to capture prey one.  Asterisks represent significant increases when compared to controls.  Error 
bars represent ±1 standard error.  
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Figure 2.3: Time to capture prey 2 for 27 day fluoxetine exposures. 
Time to capture prey two for hybrid striped bass exposed to fluoxetine for 27 days.  Treatments were 0, 10, 20, 30 
and 40 µg/L.  Asterisks represent statistical significance when compared to control. 
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Figure 2.4: Time to capture prey 2 for control and 40 µg/L treatments only. 
Time to capture prey two for hybrid striped bass exposed to fluoxetine for 27 days.  Only control and 40 µg/L 
treatments are displayed as the 40 µg/L treatment was the only concentration to show consistent significant 
increases in time to capture prey two.  Asterisks represent significant increases when compared to controls.  Error 
bars represent ±1 standard error.   
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Figure 2.5: Time to capture prey 3 for 27 day fluoxetine exposures. 
Time to capture prey three for hybrid striped bass exposed to fluoxetine for 27 days.  Treatments were 0, 10, 20, 30 
and 40 µg/L.  Asterisks represent statistical significance when compared to control.  
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Figure 2.6: Time to capture prey 3 for control and 40 µg/L treatments only. 
Time to capture prey three for hybrid striped bass exposed to fluoxetine for 27 days.  Only control and 40 µg/L 
treatments are displayed as the 40 µg/L treatment was the only concentration to show consistent significant 
increases in time to capture prey three.  Asterisks represent significant increases when compared to controls.  
Error bars represent ±1 standard error.  
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CHAPTER THREE: 
THE EFFECT OF VENLAFAXINE ON THE PREDATION BEHAVIOR AND 
BRAIN CHEMISTRY OF HYBRID STRIPED BASS 
Introduction 
 Venlafaxine is a serotonin and norepinephrine reuptake inhibitor that is 
marketed under the trade name Effexor®.  In the past five years detection of 
venlafaxine in the environment has become quite frequent.  Concentrations 
reported in the literature included 672 ng/L downstream of a wastewater 
treatment plant (WWTP) in Boulder Creek, CO, 690 ng/L downstream of a 
WWTP in Four Mile Creek, IA [1], 57 ng/L in metropolitan rivers and 300 ng/L in 
WWTP effluent in Madrid Spain [2, 3].  Concentrations as high as 808 ng/L and 
901 ng/L were found in the treated effluent and downstream, respectively, of a 
WWTP in the Grand River, Ontario, Canada [4].  The highest reported values of 
>2 µg/L were found in WWTP effluent from a metropolitan wastewater treatment 
plant in St. Paul, MN [5].  Unpublished data have shown concentrations an order 
of magnitude higher than values reported in the literature (Dr. Melissa M. Schultz, 
College of Wooster, Personal Correspondence, 2010). 
 The mode of action of venlafaxine works through blocking serotonin 
(SERT) and norepinephrine (NET) reuptake transporters on the axons of 
presynaptic neurons.  The ultimate goal of this mode of action is increasing 
neurotransmitters in the synapses of the brain.  This results in increased nerve 
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impulses which have been shown to have a positive effect on depressive 
disorders [6, 7].  These monoaminergic biochemical pathways are highly 
conserved in fish [6] and have been implicated in a number of behaviors 
including feeding [8], locomotion [9], and aggression [10]. 
 While venlafaxine is marketed as a serotonin and norepinephrine reuptake 
inhibitor, it has a much higher affinity for SERT; its binding affinity for NET is 
relatively low compared to other antidepressants designed specifically to effect 
norepinephrine reuptake. The inhibition constant (Ki) of an antidepressant is a 
measure of the concentration required to displace 50% of the natural ligand of 
the receptor.  For venlafaxine, one study found the Ki for NET was 1644 nmol/L 
compared to its Ki for SERT, which was 102 nmol/L.  In the same study, for the 
antidepressant, fluoxetine, a well-known SSRI, the Ki for inhibition of SERT was 
20 nmol/L and 2186 for NET [11].  Therefore, venlafaxine may not be as effective 
in modulating serotonin as fluoxetine but its increased modulation of 
norepinephrine may result in different effects.  It is important to note that these 
inhibition constants were for human SERT and NET and that similar constants for 
fish have not been developed for these chemicals.   
 While concentrations of venlafaxine found in aquatic matrices have been 
orders of magnitude higher than SSRI antidepressants, its toxicity to aquatic 
organisms has not been examined extensively.  Exposure to environmentally 
relevant concentrations of venlafaxine (305 and 1104 ng/L) did not have an effect 
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on male fathead minnow (Pimephales promelas) reproductive behavior.  
However, there was significant reduction in survival of exposed males, with 
~60%, and ~75% survival in 305 ng/L and 1104 ng/L exposed, respectively [12].  
Exposures of embryonic fathead minnows to 500 ng/L venlafaxine caused 
increased latency, time before initiation of escape response, and decreased total 
escape response to stimuli after hatching.  Fathead minnows exposed to 5000 
ng/L of venlafaxine for 12 days after hatching exhibited increased latency and 
decreased escape responses to stimuli [13]. 
 The objective of the current study was to determine the effect of the 
antidepressant venlafaxine on the predation behavior and brain chemistry of 
hybrid striped bass using a predator prey bioassay designed in our laboratory 
[14].  Previous research using this assay showed that six day exposures to 
fluoxetine caused increased time to capture prey at concentrations as low as 35 
µg/L.  This decrease in time to capture prey was correlated with a decrease in 
brain serotonin levels in bass [8].  Additional research showed that exposure 
durations greater than six days did not increase behavioral toxicity in bass [15].  
Therefore, we chose a six day exposure scenario with a six day recovery period.  
This objective was completed to test the following hypotheses:  
1. Bass exposed to venlafaxine will have decreased brain serotonin and 
norepinephrine levels. 
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2. Bass will recover brain serotonin and norepinephrine levels after a 
depuration period. 
3. Decreased brain neurotransmitter levels will cause increased time to 
capture prey, and recovered brain neurotransmitter levels will result in 
recovery of feeding efficiency. 
Materials and Methods  
Test Chemicals 
 Venlafaxine hydrochloride (LKT laboratories), sodium hydroxide, 
monochloroacetic acid, HPLC grade methanol, acetone, acetonitrile, glacial 
acetic acid, perchloric acid, tetrahydrofuran, and triethylamine were purchased 
from Fisher Scientific (Pittsburgh, PA, USA).  Trace metal grade concentrated 
hydrochloric acid was purchased from Spectrum Chemicals (Gardena, CA, USA).  
MS-222 (Tricaine-S) was purchased from Western Chemical (Ferndale, WA, 
USA).  Serotonin creatinine sulfate complex, dopamine HCl, norepinephrine HCl, 
3,4-dihydroxybenzlamine (DHBA), 5-hydroxyindoleactic acid (5-HIAA), sodium 
octyl sulfate, and disodium EDTA dihydrate were purchased from Sigma-Aldrich 
(St. Louis, MO, USA).  Water used for analytical procedures was ultra-purified 
using a Milli-Q Super-Q Filtration system (Millipore™, Billerica, MA, USA) with a 
measured resistivity of 18.2 MΩ·cm.  
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Fish 
 Hybrid striped bass (Morone saxatilis x M. chrysops) were generously 
donated from Southland Fisheries (Columbia, SC, USA) as fingerlings.   Fish 
were held in 450 L circular holding tanks in the cherry farm aquatic research lab 
at Clemson University (Clemson, SC, USA).  Holding tanks were maintained as 
flow through systems, constantly supplied with fresh water from Lake Hartwell 
(Clemson, SC, USA).  Before reaching the holding systems, water was filtered 
through a gravel bed, and sterilized with UV radiation.  Water temperature was 
maintained between 22 and 25°C using a mixture of a mbient and heated (via 
inline heater) or chilled water (via inline chiller), depending on incoming water 
temperature.  Water was constantly aerated with air stones and agitators 
(Boatcycle Inc, Henderson, TX, USA).  During holding, bass were fed a 
commercial diet (Finfish Silver 4.5 mm slow sink) purchased from Zeigler Bros, 
Inc. (Gardners, PA, USA). 
 Fathead minnows were purchased from Anderson Minnow Farm (Lonoke, 
AR, USA).  Minnows were held in 100 L holding tanks for using the same water 
as described above.  During holding, minnows were fed a commercial diet 
(Tetramin® Tropical Flakes) purchased from Dr’s Foster and Smith, Inc. 
(Rhinelander WI, USA). 
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Bass Group Training 
Because bass were grown on a pelleted feed, conditioning to live diet was 
required before the initiation of behavioral assays.   Hybrid striped bass (mass: 
249.68g ± 80.09, length: 232.81mm ± 25.63) were randomly removed from 
holding tanks and placed into a separate 300 L rectangular holding tank for group 
training.  Water conditions in this tank were the same as the holding tanks.  Bass 
were starved for three days prior to the start of group training.  On day zero of 
training, bass were fed four minnows/bass in the group training tank.  Bass were 
fed an additional four minnows/bass on day three and day six. 
Experimental Design 
 Hybrid striped bass were exposed to venlafaxine in a static exposure 
scenario for six days followed by a six day recovery period.  Exposures took 
place in 113 liter aquaria measuring 92.1 x 32.4 x 40 cm purchased from Deep 
Sea Aquatics (Garland, TX, USA).  Volumes of 80 and 40 liters were measured 
and marked on each tank for measurement of exposure volume and half renewal 
volume, respectively.  Each tank had a1.9 cm PVC vertical standpipe drilled into 
the front panel for control of water volume when maintained as a flow through.   
Water for exposure tanks was taken from Lake Hartwell (Clemson, SC, 
USA) (pH = 6.28 ± 0.17, hardness 24 mg/L as CaCO3, alkalinity 10 mg/L as 
CaCO3).  Before entering the laboratory, water was filtered through a gravel bed 
and UV sterilized.  Temperature was maintained via a mixing valve (M & M 
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Control Services, Grayslake, IL, USA) combining ambient water with either 
chilled (via inline chiller) or heated (via inline water heater) water, depending on 
temperature of lake water.  Water was then passed through a multi-resin filtration 
system (Water and Power Technologies, Columbia, SC, USA) for additional 
cleanup and dispensed into tanks.  Each tank was constantly aerated via air 
stones and covered with two square grated covers. 
Hybrid striped bass were removed from the group training tank and placed 
into individual aquaria (one bass/tank).  Bass were allowed to acclimate to the 
aquaria for nine days.  During the acclimation period, bass were fed four fathead 
minnows (approximately four cm long) on days three and six.  The time to 
capture each minnow was recorded for selection of fish for exposures.   
Three days after the final individual training (day zero of exposure) the first 
feeding event was quantified before the addition of venlafaxine.  Before each 
feeding event, half of the tank cover and the air stones were removed from each 
tank and fish were allowed five minutes to adjust.  Four fathead minnows 
(approximately four cm long) were dropped into tanks, and bass were allowed 25 
minutes to consume all minnows.  The time bass took to capture each minnow 
was recorded.  Any minnows not consumed during the 25 minute feeding period 
were removed, and a time to capture of 1500 seconds (25 minutes) was 
assigned for each unconsumed minnow.  Air stones and covers were replaced 
following the feeding event.  Only bass that consumed at least three minnows 
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during the day zero feeding event, and exhibited comparable feeding during the 
previous individual training days were selected for inclusion in the test.  Following 
the feeding event, incoming water was shut off and all tanks were set to the final 
test volume of 80 L.  Tanks were then randomized, assigned treatments (one 
bass per replicate tank, five tanks per treatment), and spiked with appropriate 
volumes of venlafaxine to reach nominal concentrations.  Concentrations tested 
were 0, 50, 250, and 500 µg/L.   
 Additional feeding events took place on days three and six.  Following the 
feeding event on day 6 fresh water flows were turned on to flush the venlafaxine 
from the tanks.  Flow rates were set at 0.22 liters per minute, resulting in a 
hydraulic retention time of ~2.7 hours in our system.  This allowed for ~8.8 
turnovers in a 24 hour period.  Additional feeding events took place on days nine 
and twelve to measure behavioral recovery after contaminant removal.   
Water quality (pH, D.O. temperature) was measured during each feeding 
event using a YSI 556 multi-parameter instrument (Yellow Springs Instruments, 
Yellow Springs, OH, USA).  During the exposure and recovery period, five 
replicate bass were removed from each treatment after each feeding event and 
euthanized for collection of brain tissue.  Because the number of exposure tanks 
was limited, four tests were conducted in series (12, 9, 6, and 3 days) to produce 
sufficient replicates for tissue collection.     
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Venlafaxine Exposures 
Stock solutions of venlafaxine were prepared by dissolving venlafaxine 
HCl in methanol.  Concentrations of stock solutions were selected to ensure <0.1 
mg/L methanol in exposure tanks, the ASTM recommendation for methanol as a 
carrier solvent (ASTM E1241-92).  Equivalent volumes of the stock solutions 
were added to tanks to reach nominal concentrations.  Total methanol 
concentrations for the highest treatment were calculated and control tanks were 
spiked with equivalent amounts to ensure there was no carrier solvent toxicity.  
After a two hour equilibration period, water samples were extracted from each 
tank to measure venlafaxine concentrations via HPLC with a fluorescence 
detector.  Nominal concentrations selected for the test were 0, 50, 250, 500 µg/L.  
Stock solutions were prepared daily. 
Stability of Venlafaxine 
 The stability of venlafaxine in our system was measured to determine if re-
spiking was necessary to maintain constant exposure concentrations.  Prior to 
the initiation of behavioral studies, a six day exposure was performed, using the 
same experimental setup as described above using three replicate 
bass/treatment.  Water samples were extracted from each tank daily and 
measured to determine venlafaxine concentrations.    
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Venlafaxine Analysis 
 The concentration of venlafaxine in each exposure tank was measured on 
day zero and day six of exposures.  One tank for each treatment was also 
sampled on day seven to ensure removal of venlafaxine from the tanks.  Water 
samples from tanks were adjusted to a pH of approximately three with 
concentrated hydrochloric acid.  Samples were extracted on 6 ml C-18 solid 
phase extraction cartridges with a bed weight of 500 mg (HyperSep C18 SPE 
cartridge, Thermo Fisher Scientific, Pittsburgh, PA, USA).  Prior to extraction, 
cartridges were equilibrated with 6 ml of acetone, 6 ml methanol, 6 ml Milli-Q 
water in order.  Samples were then loaded onto the cartridges and they were 
allowed to dry under vacuum. Cartridges were stored at -20°C until elution and 
analysis.   
 Cartridges were eluted with methanol/1% acetic acid and stored in 
sample vials for HPLC analysis.  The HPLC consisted of a Waters 1525 Breeze 
HPLC Pump with a Water 717 Plus auto sampler and a Waters 2475 multi 
wavelength fluorescence detector (Waters, Milford, MA, USA).  The mobile 
phase consisted of 40 parts HPLC grade acetonitrile: 60 parts Milli-Q water, pH 
adjusted to 3.0 with glacial acetic acid: 4 parts triethylamine. The mobile phase 
was filtered through a 0.2 µm nylon filter and degassed using a sonication bath.  
The flow rate was set at 1 ml/min and a 20 µl injection volume was used.  A 
Varian Polaris C-18A reverse phase analytical column (250 mm long, 4.6 mm 
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I.D.) was used to achieve chromatographic separation.  The fluorescence 
detector was set at excitation wavelength 275nm and emission wavelength 
305nm.  Run times were approximately 5 minutes per sample.   
Brain Tissue Preparation 
 Bass were euthanized after each feeding event by immersion in MS-222 
until opercular movement ceased.  Brains were quickly removed and stored at -
80°C until processing.  For monoamine analysis brai ns were weighed and 1 mL 
of 0.1N perchloric acid was added to the sample container.  Samples were 
sonicated at 20% amplitude for 10 seconds with a Branson Sonifier (model S-
450) probe sonicator (Emerson Electric Co, Danbury, CT, USA).  Samples were 
then centrifuged at 25,000 RPM (57,000 G) for 25 minutes at 4°C to remove 
cellular debris.  Supernatant was removed and placed in a 1.5 mL 
microcentrifuge tube and centrifuged again at 17,000G for 15 minutes to ensure 
complete removal of debris.  A 200 µL aliquot was taken from the supernatant 
and spiked with 50 ppb DHBA (internal standard).  Samples were stored at -80°C 
until analysis.  Another 5 µL aliquot was taken from the supernatant and diluted 
in 20 µL of 0.1N perchloric acid for protein concentration analysis.   
Protein Concentration Analysis 
 Brain protein concentrations were measured using a BCA™ Protein Assay 
Kit (Pierce, Rockford, IL, USA).  Aliquots from brain extracts were diluted 1:4 in 
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0.1N perchloric acid before analysis.  Brain monoamine concentrations were 
normalized to protein concentrations.   
Monoamine Analysis 
 Brain samples were analyzed for serotonin (5-HT), dopamine (DA), 
norepinephrine (NE), 5-HIAA, and DHBA via HPLC with an electrochemical 
detector using a method modified from Lin and Pivorun [16].  The 
chromatographic system consisted of a Rainin Rabbit HPX HPLC pump, with a 
Bioanalytical Systems LC-4C amperometric detector.  Chromatographic 
separation was achieved with an ODS-2 Hypersil 250mm x 4.6 mm C18 reverse 
phase analytical column (Fisher Scientific, Pittsburgh, PA).  Aliquots of 50 µL 
were injected into a 20 µL sample loop of a rotary injection valve.  The flow rate 
was set to 1.0 mL/min and the electrode potential was maintained at +0.8 volts 
vs. Ag/AgCl.  Sample run times were approximately 27 minutes. 
 The mobile phase consisted of 14.2 g monochloroacetic acid, 4.7 g 
sodium hydroxide, 10.0 mg disodium EDTA, 150 mg sodium octyl sulfate 
dissolved in 934 mL of Milli-Q water with 30 mL of methanol and 36 mL of 
tetrahydrofuran.  The mobile phase was filtered through a 0.45 µm nylon filter 
(Millipore™, Billerica, MA, USA) and degassed via sonication bath before use. 
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Data Analysis 
Time to capture prey was analyzed using Statistical Analysis Software 9.2 
(SAS, Cary, NC, USA).  A general linear means for mixture distributions (PROC 
GLIMMIX) procedure was used to perform a two factor ANOVA utilizing 
treatment and day as independent variables and tank as a random variable.  The 
time to capture prey data were non-normally distributed with non-homogenous 
variances.  The GLIMMIX procedure uses an analysis matrix that accounts for 
non-normal distribution and non-homogenous variances in data points.   Least 
squared means was used to perform multiple pairwise comparisons of data and 
differentiate statistical differences across and within treatment, day, and 
treatment by day interactions. 
Brain monoamine data also exhibited non-homogenous variances; 
therefore the general linear means for mixture distributions was used to perform 
a two factor ANOVA utilizing treatment and day as independent variables and 
tanks as a random variable.  Least squared means was used to perform multiple 
pairwise comparisons of data and differentiate statistical differences across and 
within treatment, day, and treatment by day interactions. 
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Results 
Water Quality Measurements 
Water quality measurements were averaged (mean ± standard deviation) 
for the entire test.  pH, dissolved oxygen, and temperature were 6.91 ± 0.33, 8.46 
mg/L ± 0.63, and 22.76°C ± 1.75, respectively. 
Venlafaxine Stability 
Results for day zero and day six of the venlafaxine stability study are 
presented in Figure 3.1.  Concentrations of venlafaxine remained stable over a 
six day exposure period.  Therefore, tanks were not re-spiked during behavioral 
exposures and concentrations were only measured on days zero and six.  
Venlafaxine Concentrations 
The average concentration (mean ± standard deviation) over the entire 
test for 50, 250, and 500 µg/L treatments were 35.68 ± 6.75, 198.67 ± 22.21, and 
465.39 ± 43.68 µg/L, respectively.  
Behavioral Assays 
 Complete numerical results from behavioral assays are presented in Table 
A-2 of the appendix.  After three days of exposure to 250 µg/L venlafaxine there 
was a statistically significant increase in time to capture prey one when 
compared to controls (Figure 3.2).  By day six the time to capture prey for both 
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the 250 and 500 µg/L treatments were significantly increased over controls.  After 
three days of depuration, on day nine only the 250 µg/L treatments remained 
significantly increased.  Finally on day twelve (six days of depuration) all 
treatments returned to control levels. 
 The time to capture prey two is presented in Figure 3.3.  The 250 and 500 
µg/L treatments were significantly increased when compared to controls on day 
three and day six.  Following a three day recovery period (day nine), only the 250 
µg/L treatment was significantly increased over controls.  Though the 250 and 
500 µg/L treatments seem elevated over controls on day twelve (six days of 
depuration) there was no significant difference between these treatments and the 
controls.     
 The time to capture prey three for hybrid striped bass exposed to 
venlafaxine is presented in Figure 3.4.  The 250 and 500 µg/L treatments were 
significantly increased over controls by day three.  By day six all three 
venlafaxine treatments were significantly increased.  The 50, 250, and 500 µg/L 
treatments remained elevated over controls after three and six days of 
depuration (days nine and twelve, respectively). 
 The time to capture prey four data are not presented graphically as they 
were highly variable for both treatments and controls.  Therefore, there were no 
statistically significant increases in time to capture prey in treatments when 
compared to controls. 
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 In general the 250 and 500 µg/L treatments caused significant increases 
in time to capture prey one, two, and three with the exception of day three, when 
only the 250 µg/L treatment was significant.  While these treatments were able to 
recover their ability to capture prey one and two after removal of venlafaxine, 
their time to capture prey three was still significantly increased over controls after 
six days of depuration.  The lowest concentration tested, 50 µg/L, did not cause 
any significant increase in time to capture prey one and two on any day.  But by 
day six the time to capture prey three was significantly increased when compared 
to controls.  The time to capture prey three for the 50 µg/L treatment remained 
significantly elevated after six days of depuration. 
Qualitative Behavioral Observations 
 In addition to our quantitative behavioral measurements we also noted a 
number a qualitative behavioral changes in the 250 and 500 µg/L treatments. 
These observations were not compared among treatments as they were not 
scored quantitatively.  Some of the observations included spitting out prey fish, 
trouble swallowing prey, maintaining a vertical position in the water column, 
erratic swimming, swimming with dorsal surface out of the water, and gulping for 
air at the surface.  
Brain Chemistry 
 Brain concentrations of norepinephrine, dopamine, 5-HT and 5-HIAA are 
presented graphically in Figures 3.5, 3.6, 3.7, and 3.8 respectively (values for 5-
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HT and 5-HIAA are presented in the appendix Table A-3).  There were no 
significant effects on brain norepinephrine and dopamine levels throughout the 
exposure and recovery period.  There was a significant reduction in brain 
serotonin concentrations when compared to controls on day 3 for the highest 
concentration, 500 µg/L.  On day six all three venlafaxine concentrations were 
associated with statistically significant decreases in brain serotonin levels.  
Though an effect was seen for all three venlafaxine concentrations, the 
corresponding serotonin concentrations were not decreased in a dose dependent 
manner.  Serotonin concentrations for the 50, 250, and 500 µg/L concentrations 
were similar and were not statistically different from each other.  On day nine 
(recovery period) only the 500 µg/L treatment remained decreased when 
compared to controls and all brain serotonin levels had returned to control levels 
by day twelve.   
There were also changes in 5-HIAA (primary metabolite of serotonin) 
levels in the brains of exposed hybrid striped bass.  By day three all three 
exposure concentrations caused significant decreases in 5-HIAA levels.  These 
levels remained significantly decreased through day nine.  By day twelve, 5-HIAA 
levels had all returned to control levels with the exception of the highest 
treatment. 5-HIAA/5-HT ratio can be an indicator of how serotonin is changing 
over time and results are presented in Figure 3.9.  There were no significant 
effects on brain 5-HIAA/5-HT ratio with the exception of the 500 µg/L treatment 
on day six, which was significantly decreased compared to controls and the other 
 83 
 
treatments.  This is due to 5-HT concentrations leveling out by day six while 5-
HIAA levels continued to decrease.   
 Because serotonin was the only measured neurotransmitter that was 
significantly affected by venlafaxine, brain serotonin levels as a function of 
venlafaxine concentration are presented in Figure 3.10.  On day three of 
venlafaxine exposure brain serotonin concentrations decreased in a linear dose 
dependent manner.  But by day six of exposure serotonin concentrations in the 
brains had reached a basal level for all venlafaxine treatments, indicating a 
saturation of the effect of venlafaxine. 
Behavior/Brain Chemistry Effects 
 The correlation between brain serotonin concentrations and the time to 
capture prey for hybrid striped bass exposed to venlafaxine are presented in 
Figure 3.11.  There was an exponential increase in the time to capture prey one 
and three as a function of brain serotonin levels.  This was due to the similar 
approximate concentration of brain serotonin levels on days six, but increasing 
time to capture prey with increasing venlafaxine concentrations. 
Discussion 
 The ever increasing use of antidepressants has resulted in their presence 
in our waste streams and ultimately our aquatic ecosystems [5, 17-21].  But the 
effects of antidepressants on aquatic organisms are understudied.  
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Antidepressants have been shown to be relatively non-toxic at environmentally 
relevant concentrations using traditional toxicity testing methods [22, 23].  
However, their mode of action and intended use warrants investigation of their 
behavioral effects.    The aim of the current study was to understand how aquatic 
exposure to the antidepressant venlafaxine affects the brain chemistry and 
predation behavior of hybrid striped bass. 
The results of the current study showed that hybrid striped bass exposed 
to venlafaxine for six days at concentrations of 50, 250, and 500 µg/L had 
significant changes in brain chemistry and their ability to capture fathead 
minnows was significantly reduced.  The behavioral results indicate that 
venlafaxine may have effects on both locomotor activity as well as appetite.   At a 
low exposure concentration (50 µg/L) bass were able to efficiently capture their 
first two fish in times comparable to controls but had significant increases in time 
to capture their third prey.  This may indicate that venlafaxine may act as an 
appetite suppressant at low concentrations while not having an inhibitory effect 
on locomotor activity.  Antidepressants that effect serotonin have been shown to 
suppress appetite in mammals [24].  Higher concentration exposures resulted in 
increased time to capture prey one and two on day six.  While this could indicate 
further suppression of appetite and not necessarily an effect on locomotor 
activity, several missed attempts were also observed at these concentrations 
indicating it could be a combination of the two effects.  Serotonin has also been 
implicated in controlling locomotor activity in fish [10].      
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Brain chemistry data showed that venlafaxine caused significant 
decreases in brain serotonin concentrations.  These results are counterintuitive 
as the expected therapeutic effect of venlafaxine is increased brain serotonin and 
norepinephrine concentrations.  But the mammalian literature has shown that 
short term exposure to antidepressants may initially cause decreased brain 
serotonin levels [25].  When SSRI and SNRI antidepressants are bound to 
monoamine reuptake transporters, un-recycled monoamines can activate 
negative feedback loops that are responsible for maintenance of neuronal 
monoamine concentrations.  This is accomplished through binding of 
autoreceptors on the axon terminal of the pre-synaptic neuron.  Binding of these 
autoreceptors inhibits additional release of monoamines into the synaptic cleft.  
This feedback inhibition mechanism is thought to initially decrease monoamine 
release in turn decreasing overall monoamine concentrations.  Over time the 
auto receptors may become desensitized and allow further release of 
monoamines, permitting the therapeutic function of the chemical.  This process 
may take 2-4 weeks to run its course [25].  Initial decreases in serotonin 
concentrations, potentially due to this phenomenon, were also observed when 
hybrid striped bass were exposed to fluoxetine for six days [8] as well as in Betta 
splendens injected with fluoxetine for 14 days [26].       
The primary metabolite of serotonin, 5-hydroxyindoleacetic acid (5-HIAA) 
is often measured with serotonin as it can give an indication of how serotonin is 
changing in the brain.  Administration of serotonin modulating antidepressants 
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might be expected to cause increases in 5-HIAA level due to the decrease in 
reuptake of serotonin and increased metabolism by monoamine oxidases.  
Stress has also been shown to increase 5-HIAA concentrations in the brains of 
artic charr [27].  But in the current study 5-HIAA levels mirrored decreasing 
serotonin levels up to day six.  These data are consistent with the decreased 
serotonin concentrations in the current study and decreases in 5-HIAA 
concentrations during SSRI antidepressants have also been reported in hybrid 
striped bass [8] and Betta splendens [26] as well as rats exposed to the SSRI 
antidepressant citalopram [28].  
Even after three days of depuration, 5-HIAA levels decreased to their 
lowest measured level.  These results may indicate that though serotonin 
concentrations in the 50 and 250 µg/L returned to control levels after three days 
of depuration, 5-HIAA levels were still significantly decreased.  We hypothesized 
that the brain was suppressing the metabolism of serotonin in an attempt to 
regain serotonin homeostasis.   
Results from the current study did not show any significant effects on brain 
norepinephrine concentrations even though venlafaxine is known to interact with 
both the serotonin and norepinephrine transporter.  This may be due to the large 
difference in the affinities of venlafaxine for the respective serotonin and 
norepinephrine reuptake transporters (SERT and NET).  While receptor affinity 
data for this chemical are not available for fish, results in mammalian systems 
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have shown that venlafaxine has a high affinity for the SERT (Ki = 102 nmol/L) 
and a relatively low affinity for the NET (Ki = 1644 nmol/L) [11].  Therefore, it 
would take an order of magnitude higher concentration of venlafaxine to cause a 
comparable effect on norepinephrine to the effect of the venlafaxine on serotonin 
concentrations in this study. 
Examination of correlations between venlafaxine concentrations and brain 
chemistry reveal that venlafaxine initially decreases serotonin in a dose 
dependent manner (Figure 3.10, day three data); however, over time this 
decrease reaches saturation resulting in apparent basal levels (Figure 3.10, day 
six data).  Previous studies with hybrid striped bass exposed to the SSRI 
antidepressant fluoxetine showed a dose dependent decrease in brain serotonin 
concentrations as a function of increasing fluoxetine concentrations [8].  While 
this was the case for venlafaxine on day three, serotonin decrease was saturated 
on day six indicating a difference between the effects of the two antidepressants.  
This could potentially be related to the differences in their stability in our 
exposure system.  Fluoxetine had a previously determined half-life of three days 
in our exposure system while venlafaxine concentrations were stable over six 
day exposures [8].  Therefore, fluoxetine had to be re-spiked every three days 
during exposures to maintain relatively constant exposure concentrations.  In 
spite of this, the fluoxetine concentrations changes by as much as 50 % between 
day zero and day three and between day three and day six.  We hypothesized 
that fluctuations in exposure may have resulted in less fluoxetine being absorbed 
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and ultimately reaching the brain while venlafaxine may have had more time to 
interact with its targets due to its increased stability.   
When examining this hypothesis in the context of aquatic toxicology 
literature, fluctuating exposure concentrations have been shown to be less toxic 
than continuous exposures to peak episode concentrations for non-
bioaccumulative contaminants such as acids and some metals [29].   But the 
toxicity of fluctuating exposures to more lipophilic contaminants can be 
dependent on body burden, half-life in the animal, and reversibility of the toxic 
mechanism [30].  Antidepressants like fluoxetine have been shown to 
bioaccumulate in the tissues of fish [1, 31], and have been shown to have a 
relatively long biological half-life (9.4 ± 1.1 days) in Japenese medaka (Oryzias 
latipes) [32].  But the toxic effects of low concentration exposures to venlafaxine 
have been shown to be fairly reversible in the current study, as well as our 
previous study with fluoxetine [8]. Without the measurement of body burdens in 
the current study, the differences in these factors make it hard to determine if 
fluctuating concentrations of fluoxetine were the cause of a lower effect on 
serotonin concentrations when compared to venlafaxine.  
Correlations between brain serotonin levels and behavior were not quite 
as clear because brain serotonin concentrations were approximately the same 
for all exposure concentrations on day six but there were differences in 
behavioral data between treatments. Hybrid striped bass exposed to fluoxetine 
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exhibited a linear relationship between increasing time to capture prey and 
decreasing brain serotonin levels [8].  A similar relationship could not be 
established in the current study as all treatments caused a decrease of serotonin 
to basal levels by day six.  We hypothesized that modulation of serotonin in 
tissues other than the brain may have caused the increase in time to capture 
prey for higher venlafaxine concentrations once brain serotonin concentrations 
had been depressed to a basal level.  For example serotonin containing neurons 
have been found in enteric (gastrointestinal) nervous system of fish [33].  
Serotonin has been shown to play a role in gut motility in goldfish (Carassius 
auratus), which may influence appetite [34]. Cells containing serotonin have been 
found in the pineal gland of fish, an organ that plays a role in a number of 
physiological and behavioral processes [35].  Serotonin may also influence 
appetite and behavior through modulation of downstream processes.  Serotonin 
has been implicated in controlling the release of various hormones in fish 
including growth hormone, and gonadotropins, hormones responsible for 
regulating growth and reproductive function [36].  Release of cortisol, a hormone 
associated with stress response that is responsible for nutrient metabolism and 
immune suppression, has also been shown to be controlled by serotonin 
receptors [37-39].  Corticotropin-releasing factor, a neuropeptide implicated in 
controlling behavior in a number of vertebrates, including fish, may also be 
regulated by serotonergic systems [40].   
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Other laboratories investigating the effects of venlafaxine in fish have 
shown that venlafaxine does not always act in a dose dependent manner.  Adult 
fathead minnows exposed to venlafaxine for 21 days had increased mortality at 
lower exposure concentrations when compared to higher concentrations and 
controls [12].  Fathead minnow embryos exposed to low concentrations of 
venlafaxine exhibited increased latency to escape response and decreased total 
escape response when compared to controls and higher levels of venlafaxine 
[13].  These studies indicate that over time lower doses of venlafaxine may be 
just as effective as or more effective than high doses.  While brain chemistry was 
not measured in these other studies, this could be due to venlafaxine causing 
serotonin to decrease to its basal level. 
Behavioral results from this study indicate that venlafaxine has less of an 
effect than fluoxetine.  Fluoxetine concentrations as low as 35 µg/L (nominal) 
were shown to cause significant reduction in the ability of hybrid striped bass to 
capture prey one, two, and three [8] while the lowest concentration tested in the 
current study (50 µg/L nominal) only caused a significant effect on the time to 
capture prey three.  Fluoxetine caused a 49% reduction in brain serotonin levels 
at the highest level tested (150 µg/L nominal, day nine) [41].  The current study 
also had a maximum reduction of 49% of serotonin but the concentration 
required to cause this effect was 500 µg/L (day three).  While all exposure 
concentrations eventually reached a basal threshold on day six, the maximum 
percent reduction of serotonin on this day was 36% (50 µg/L nominal). The 
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differences in the effects of these chemicals on serotonin can be explained by 
differences in receptor affinity because fluoxetine has a factor of five lower Ki for 
SERT (20 nmol/L) when compared to venlafaxine (102 nmol/L) [11].   
Venlafaxine has been measured in wastewater effluent at concentrations 
as high as 2 µg/L [5].  Venlafaxine has also been shown to cause significant 
effects on predator avoidance behavior at environmentally relevant 
concentrations [13].    While the results of the current study indicate that 
venlafaxine does have an effect on the brain chemistry and behavior of hybrid 
striped bass, it is important to note that concentrations are at the high end of 
environmentally measured concentrations.  Since municipal wastewater effluents 
contain many SSRIs future research should focus on exposure to multiple 
antidepressants that have a similar mode of action to determine if they are 
additive. 
Conclusions 
 Hybrid striped bass exposed to venlafaxine exhibited increased time to 
capture prey when compared to controls.  Low concentration exposures may 
affect appetite while higher concentration exposures may also affect locomotor 
activity.  Exposure to venlafaxine for three days resulted in a dose-dependent 
decrease in brain serotonin concentrations while six day exposure caused 
reduction to an apparent basal level.  Unfortunately, brain serotonin 
concentrations were not predictive of behavioral changes.  Mammalian receptor 
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affinity data were able to explain the difference in potency of venlafaxine and 
fluoxetine. 
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Figure 3.1: Stability of venlafaxine over 6 days. 
 
Concentrations of venlafaxine on day 0 and day 6 of stability study. Error bars 
represent ±1 standard deviation.
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Figure 3.2: Time to capture prey 1 for hybrid striped bass exposed to venlafaxine. 
Time to capture prey 1 for hybrid striped bass exposed venlafaxine for 6 days and allowed to recover for 6 days.  
Treatments were 0, 50, 250, and 500 µg/L.  Asterisks represent statistical significance when compared to control.  
Error bars represent ±1 standard error. 
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Figure 3.3: Time to capture prey 2 for hybrid striped bass exposed to venlafaxine. 
Time to capture prey 2 for hybrid striped bass exposed venlafaxine for 6 days and allowed to recover for 6 days.  
Treatments were 0, 50, 250, and 500 µg/L.  Asterisks represent statistical significance when compared to control.  
Error bars represent ±1 standard error.  
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Figure 3.4: Time to capture prey 3 for hybrid striped bass exposed to venlafaxine. 
Time to capture prey 3 for hybrid striped bass exposed venlafaxine for 6 days and allowed to recover for 6 days.  
Treatments were 0, 50, 250, and 500 µg/L.  Asterisks represent statistical significance when compared to control.  
Error bars represent ±1 standard error. 
0
200
400
600
800
1000
1200
1400
1600
0 3 6 9 12
T
i
m
e
 
(
s
e
c
o
n
d
s
)
 
Day
Control 50 µg/L 250 µg/L 500 µg/L
Exposure Recovery
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
  
97
 
 
 
Figure 3.5: Brain norepinephrine concentrations in hybrid striped bass exposed to venlafaxine. 
Brain norepinephrine concentrations for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Error bars represent ±1standard deviation.   
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Figure 3.6: Brain dopamine concentrations in hybrid striped bass exposed to venlafaxine. 
Concentrations of dopamine in the brains of hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 
day recovery period.  Asterisks represent statistical significance when compared to controls.  Error bars represent 
±1 standard deviation. 
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Figure 3.7: Brain serotonin concentrations in hybrid striped bass exposed to venlafaxine. 
Concentrations of serotonin in the brains of hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 
day recovery period.  Asterisks represent statistical significance when compared to controls.  Error bars represent 
±1 standard deviation. 
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Figure 3.8: Brain 5-HIAA concentrations in hybrid striped bass exposed to venlafaxine. 
Concentrations of 5-HIAA in the brains of hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Asterisks represent statistical significance when compared to controls.  Error bars represent ±1 
standard deviation. 
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Figure 3.9: 5-HIAA/5-HT ratios in hybrid striped bass exposed to venlafaxine. 
5-HIAA/5-HT ratios in the brains of hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Asterisks represent statistical significance when compared to controls.  Error bars represent ±1 
standard deviation. 
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Figure 3.10: Brain serotonin levels as a function of measured venlafaxine concentration. 
Brain serotonin concentrations as a function of measured venlafaxine concentrations on days 3 and 6.  A linear 
equation was used to fit a curse to the data for day three.  A linear equation was used to fit a curve to the data for 
venlafaxine treatments on day 6.  Equations and correlation coefficients are displayed above and below the 
respective curves.  
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 Figure 3.11: Time to capture prey as a function of brain serotonin levels on day 6. 
Time to capture prey 1 and 2 for hybrid striped bass exposed to venlafaxine for 6 days as a function of brain 
serotonin concentrations.   
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CHAPTER FOUR:  
THE EFFECT OF MIXTURES OF FLUOXETINE AND VENLAFAXINE ON THE 
PREDATION BEHAVIOR AND BRAIN CHEMISTRY OF HYBRID STRIPED 
BASS 
Introduction 
 Increased use of pharmaceuticals and personal care products (PPCPs) 
has led to increased concentrations in municipal wastewater effluents and 
receiving streams [1-6]. Antidepressants are among the most frequently detected 
classes of pharmaceuticals.  The antidepressants fluoxetine (Prozac®), 
venlafaxine (Effexor®), bupropion (Wellbutrin®), sertraline (Zoloft®), paroxetine 
(Paxil®), citalopram (Celexa®), fluvoxamine (Luvox®) and duloxetine (Cymbalta®) 
have all been detected in the nanograms per liter to low micrograms per liter 
concentrations in environmental matrices [1, 2, 6].   
The relative hazard of some of these compounds to aquatic organisms 
has been studied.  The 48-hour acute toxicity of fluoxetine in three commonly 
used toxicity test species (Pimephales promelas, Ceriodaphnia dubia, Daphnia 
magna) was similar with LC50 values (median lethal concentration) between 234 
and 820 µg/L [7].  The 48-hour LC50 for larval fathead minnows and C. dubia 
exposed to sertraline was 205 (pH 7.5) and 146-202 µg/L, respectively [8, 9].  
The 48-hour LC50 for C. dubia exposed to paroxetine and citalopram was 734 - 
1175 and 3396 - 4713 µg/L, respectively [9]. The general consensus is that 
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antidepressants are not toxic at environmentally relevant concentrations using 
traditional toxicity tests.   
These antidepressants specifically target the transport of monoamine 
neurotransmitters into pre-synaptic axons in the brains of humans.  Through this 
pathway monoamine concentrations are modulated in an effort to treat a number 
of depressive disorders [10].  Monoaminergic transport proteins and receptors in 
fish have been shown to share high genetic sequence identity with a number of 
mammal species, and therefore may be expected to exhibit similar responses to 
antidepressants [11, 12]. The monoamine neurotransmitters serotonin, 
norepinephrine, and dopamine have been implicated in stress response [13], 
feeding [14], locomotor activity [15], social hierarchies [16], and migration [17] in 
fish.  The potential for antidepressant effects on brain monoamines, and 
subsequent behaviors has led researchers to examine the behavioral effects of 
antidepressants in fish.   
The antidepressant fluoxetine has been shown to decrease escape 
velocity and total escape response after a stimulus in embryonically exposed 
fathead minnows (Pimephales promelas) [18].  Gulf toadfish injected with 
fluoxetine exhibited increased aggression, which coincided with increased 
plasma serotonin levels [19].  Intraperitoneal injections of fluoxetine have been 
shown to cause decreased aggression in bluehead wrasse (Thalassoma 
bifasciatum) [20].  Exposures of embryonic fathead minnows to venlafaxine 
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caused increased latency, the time before initiation of escape response, and 
decrease total escape response to stimuli after hatching.  Fathead minnows 
exposed to venlafaxine for 12 days after hatching exhibited increased latency 
and decreased escape responses to stimuli [18]. 
Fluoxetine caused increased time to capture prey in hybrid striped bass at 
concentrations between 30 and 40 µg/L during 6 and 27-day exposures [21, 22]. 
Increased time to capture prey was correlated with decreased brain serotonin 
levels during six day exposures [21].  Hybrid striped bass exposed to venlafaxine 
exhibited increased time to capture various prey during six day exposures to 50, 
250, and 500 µg/L.  Brain serotonin concentrations initially decreased in a dose 
dependent manner after three days before reaching an apparent minimal basal 
level for all exposure concentrations after six day exposures [22].        
While laboratory research on the effects of individual antidepressants 
have increased our understanding of how these contaminants may influence the 
behavior of aquatic organisms, environmental exposure scenarios present a 
different level of complexity.  As environmental detection data have shown, 
antidepressants in environmental matrices are present in complex mixtures [2, 
23].  However, few studies have quantified the effects of antidepressant mixtures 
on fish behavior.  Further, none have related any behavioral effects to changes in 
brain chemistry. 
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Scientists have struggled with assessing the risk of mixtures of endocrine 
disruptors as a whole for over a decade.  An EPA sponsored science advisory 
panel, convened in the late 1990s, recommended delaying the screening of 
contaminant mixtures with endocrine disrupting potential until more data was 
available for individual compounds [24]. One of the most troubling concepts in 
mixture toxicity assessment is how to address the concept of additivity.  Because 
organisms exhibit finite responses to contaminants, you cannot expect a 
chemical mixture to have an infinitely additive effect with increasing number of 
chemicals.  For example, if individual compounds with similar modes of action 
are expected to cause a 10% decrease in some endpoint (i.e. survival, gene 
expression) and you expose an organism to a mixture of 20 of these chemicals, 
you cannot have a 200% decrease in your endpoint [25].  Therefore, the concept 
of dose addition has been employed as it can account for saturation of effects so 
that paradoxical predictions that exceed the maximum effect are avoided. The 
dose addition concept states that if chemical A and chemical B act through a 
similar mode of action, chemical A can be replaced, in whole or in part, with an 
equally effective concentration of chemical B, without diminishing the combined 
effect of the two chemicals.  The most important part of this concept is the use of 
equally effective concentrations as concentrations of different chemicals cannot 
always be expected to cause similar effects.  Therefore, chemicals must me 
normalized to a specific effect and dosing regimes adjusted accordingly, if 
additivity is to be assessed [24].  Concentrations of mixtures that are normalized 
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to some effect are often described as toxic equivalency factors and are 
expressed as toxic units [26, 27]. 
The dose addition concept has frequently been applied to the assessment 
of mixture toxicity of estrogenic compounds.  Normalizing concentrations of 
estrogenic compounds in mixtures has been achieved through the use of 
estradiol equivalency factors (EEQs), which are determined by normalizing the 
magnitude of effect for a suspected estrogenic compound to the effect of the 
same concentration of estradiol [28]. EEQs have been used to predict the relative 
contribution of individual estrogenic compounds in complex mixtures of 
estrogenic compounds in wastewater effluents [29, 30].  Using mathematical 
models based of the relative potency of estradiol, ethynylestradiol, nonylphenol, 
octylphenol, and bisphenol A, researchers were able to predict the additive 
effects of mixtures on vitellogenin induction in male fathead minnows [31].  Low 
concentrations of estrogenic compounds that do not elicit effects individually 
have also been shown to cause adverse effects when combined in mixtures [31-
33].  Use of the dose addition concept has also been used to successfully to 
predict the additive effects of anti-androgens, and thyroid disrupting chemicals 
[24].  
Though the prediction of mixture toxicity using the dose addition concept 
has been widely used for other endocrine disruptor classes, research on mixtures 
of pharmaceuticals, especially antidepressants, is fairly limited. A few examples 
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include mixtures of fluoxetine, venlafaxine, sertraline, and bupropion causing 
decreased escape velocity in fathead minnow exposed as embryos and larvae, 
as well as reducing total escape response in exposed larvae [18].  Adult male 
fathead minnows exposed to an environmentally relevant mixture of sertraline, 
fluoxetine, bupropion, and venlafaxine did not exhibit effects on nest guarding 
behavior when challenged with an unexposed male [34].   
Based on results of our previous research on the individual behavioral and 
biochemical effects of fluoxetine and venlafaxine on hybrid striped bass, the goal 
of the current study was to determine if mixtures of these two pharmaceuticals 
might be additive.  To achieve this goal the following hypotheses were tested: 
1. Mixtures of fluoxetine and venlafaxine will have an additive effect on 
brain serotonin. 
2. Mixtures of fluoxetine and venlafaxine will cause increased time to 
capture prey for bass. 
3. Increased time to capture prey will correlate with changes in brain 
chemistry. 
Materials and Methods  
Test Chemicals 
 Fluoxetine hydrochloride was generously donated by Fermion (Finland).  
Venlafaxine hydrochloride (LKT laboratories), sodium hydroxide, 
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monochloroacetic acid, HPLC grade methanol, acetone, acetonitrile, glacial 
acetic acid, perchloric acid, tetrahydrofuran, and triethylamine were purchased 
from Fisher Scientific (Pittsburgh, PA, USA).  Trace metal grade concentrated 
hydrochloric acid was purchased from Spectrum Chemicals (Gardena, CA, USA).  
MS-222 (Tricaine-S) was purchased from Western Chemical (Ferndale, WA, 
USA).  Serotonin creatinine sulfate complex, dopamine HCl, norepinephrine HCl, 
3,4-dihydroxybenzlamine (DHBA), 5-hydroxyindoleacetic acid (5-HIAA), sodium 
octyl sulfate, and disodium EDTA dihydrate were purchased from Sigma-Aldrich 
(St. Louis, MO, USA).  Water used for analytical procedures was ultra-purified 
using a Milli-Q Super-Q Filtration system (Millipore™, Billerica, MA, USA) with a 
measured resistivity of 18.2 MΩ·cm. 
Fish 
 Hybrid striped bass (Morone saxatilis x M. chrysops) were purchased from 
Keo Fish Farms (Keo, AR, USA) as fingerlings.   Fish were held in 450 L circular 
holding tanks in the cherry farm aquatic research lab at Clemson University 
(Clemson, SC, USA).  Holding tanks were maintained as flow through systems, 
constantly supplied with fresh water from Lake Hartwell (Clemson, SC, USA).  
Before reaching the holding systems, water was filtered through a gravel bed, 
and sterilized with UV radiation.  Water temperature was maintained between 22 
and 25°C using a mixture of ambient and heated (via  inline heater) or chilled 
water (via inline chiller), depending on incoming water temperature.  Water was 
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constantly aerated with air stones and agitators (Boatcycle Inc, Henderson, TX, 
USA).  During holding, bass were fed a commercial diet (Finfish Silver 4.5 mm 
slow sink) purchased from Zeigler Bros, Inc. (Gardners, PA, USA). 
 Fathead minnows were purchased from Anderson Minnow Farm (Lonoke, 
AR, USA).  Minnows were held in 100 L holding tanks using the same water as 
described above.  During holding minnows were fed a commercial diet 
(Tetramin® Tropical Flakes) purchased from Foster and Smith, Inc (Rhinelander 
WI, USA). 
Bass Group Training 
Because bass were grown on a pelleted feed, conditioning to live diet was 
required before the initiation of behavioral assays.  Hybrid striped bass (mass: 
227.65g ± 47.60, length: 234.48mm ± 26.18) were randomly selected from the 
holding tanks and placed into a separate 300 L rectangular holding tank for group 
training.  Water conditions in this tank were the same as the holding tanks.  Bass 
were starved for three days prior to the start of group training.  On day zero of 
training, bass were fed four minnows/bass in the group training tank.  Bass were 
fed an additional four minnows/bass on day three and day six. 
Experimental Design 
 Hybrid striped bass were exposed to mixtures of fluoxetine and 
venlafaxine in a static exposure scenario for six days followed by a six day 
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recovery period.  Exposures took place in 113 liter aquaria measuring 92.1 x 32.4 
x 40 cm purchased from Deep Sea Aquatics (Garland, TX, USA).  Volumes of 80 
and 40 liters were measured and marked on each tank for measurement of 
exposure volume and half renewal volume, respectively.  Each tank had a 1.9 cm 
PVC vertical standpipe drilled into the front panel for control of water volume 
when maintained as a flow through system.   
Water for exposure tanks was taken from Lake Hartwell (Clemson, SC, 
USA) (pH = 6.28 ± 0.17, hardness 24 mg/L as CaCO3, alkalinity 10 mg/L as 
CaCO3).  Before entering the laboratory, water was filtered through a gravel bed 
and UV sterilized.  Temperature was maintained via a mixing valve (M & M 
Control Services, Grayslake, IL, USA) combining ambient water with either 
chilled (via inline chiller) or heated (via inline water heater) water, depending on 
the temperature of lake water.  Water was passed through a multi-resin filtration 
system (Water and Power Technologies, Columbia, SC, USA) for additional 
cleanup and dispensed into tanks.  Each tank was constantly aerated via air 
stones and covered with two square grated covers. 
Hybrid striped bass were removed from the group training tank and placed 
into individual aquaria (one bass/tank).  Bass were allowed to acclimate to the 
aquaria for nine days.  During the acclimation period, bass were fed four fathead 
minnows (approximately four cm long) on days three and six.  The time to 
capture each minnow was recorded for selection of fish for exposures.   
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Three days after the final individual training (day zero of exposure) the first 
feeding event was quantified before the addition of antidepressant mixtures.  
Before each feeding event, half of the tank cover and the air stones were 
removed from each tank and fish were allowed five minutes to adjust.  Four 
fathead minnows (approximately four cm long) were dropped into tanks, and 
bass were allowed 25 minutes to consume all minnows.  The time bass took to 
capture each minnow was recorded.  Any minnows not consumed during the 25 
minute feeding period were removed, and a time to capture of 1500 seconds (25 
minutes) was assigned for each unconsumed minnow.  Air stones and covers 
were replaced following the feeding event.  Only bass that consumed at least 
three minnows during the day zero feeding event, and exhibited comparable 
feeding during the previous individual training days were selected for inclusion in 
the test.  Following the day zero feeding event, incoming water was shut off and 
all tanks were set to the final test volume of 80 L.  Tanks were then randomized, 
assigned treatments (five bass/treatment/test), and spiked with appropriate 
volumes of venlafaxine to reach nominal concentrations.   
Concentrations were selected based on the lowest concentration that 
caused significant effects during individual fluoxetine and venlafaxine behavioral 
tests.  A toxic unit approach was taken when determining mixture concentrations.  
Concentrations of 30 µg/L for fluoxetine and 50 µg/L for venlafaxine were 
selected as one toxic unit (TU) for the individual compounds as they both 
represent an approximate 15% decrease in brain serotonin concentrations by 
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day three based on the results of our previous studies with individual exposures 
to these compounds (see table 4.1 and [21]).  Using this approach, the following 
treatments were tested: control, 1 TU (15 µg/L fluoxetine; 25 µg/L venlafaxine), 
two TU (30 µg/L fluoxetine; 50 µg/L venlafaxine), and four TU (60 µg/L fluoxetine; 
100 µg/L venlafaxine) were tested.  Assuming additivity, expected decrease in 
brain serotonin concentrations on day three for treatments of one, two, and four 
toxic units would be 15, 30, and 60%, respectively.   
 Additional feeding events took place on days three and six of exposure.  
Following the feeding event on day six, fresh water flows were turned on to flush 
the antidepressants from the tanks.  Flow rates were set at 0.22 liters per minute, 
resulting in a hydraulic retention time of ~2.7 hours in our system.  This allowed 
for ~8.8 turnovers in a 24 hour period.  Additional feeding events took place on 
days nine and twelve to measure behavioral recovery after exposure ceased.   
Water quality (pH, D.O. temperature) was measured during each feeding 
event using a YSI 556 multi-parameter instrument (Yellow Springs Instruments, 
Yellow Springs, OH, USA).  During the exposure and recovery period, five 
replicate bass were removed from each treatment after each feeding event and 
euthanized for collection of brain tissue.  Because the number of exposure tanks 
was limited, four tests were conducted in series (12, 9, 6, and 3 days) to produce 
sufficient replicates for tissue collection.     
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Antidepressant Mixture Exposures 
Stock solutions of fluoxetine and venlafaxine were prepared by dissolving 
fluoxetine HCl and venlafaxine HCl in methanol.  Concentrations of stock 
solutions were selected to ensure <0.1 mg/L methanol in exposure tanks, the 
ASTM recommendation for methanol as a carrier solvent (ASTM E1241-92).  
Equivalent volumes of the stock solutions were added to tanks to reach nominal 
concentrations.  Total methanol concentrations for the highest treatment were 
calculated and control tanks were spiked with equivalent amounts to ensure 
there was no carrier solvent toxicity.  After a two hour equilibration period, water 
samples were extracted from each tank to measure antidepressant 
concentrations via HPLC with a fluorescence detector.  Stock solutions were 
prepared daily.  Previous studies showed that fluoxetine has a half-life in our 
system of approximately three days.  Therefore, tanks were re-spiked with half 
the concentration of fluoxetine on day three of the exposures to maintain nominal 
concentrations [21].  Venlafaxine was shown to be stable in our system over six 
day periods [22]. 
Antidepressant Analysis 
 The concentrations of fluoxetine and venlafaxine in each exposure tank 
were measured on day zero.  One tank for each treatment was also measured on 
day three and day six to confirm concentrations.  Water samples from tanks were 
adjusted to a pH of approximately three with concentrated hydrochloric acid.  
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Samples were extracted on 6 ml C-18 solid phase extraction cartridges with a 
bed weight of 500 mg (HyperSep C18 SPE cartridge, Thermo Fisher Scientific, 
Pittsburgh, PA, USA).  Prior to extraction, cartridges were equilibrated with 6 ml 
of acetone, 6 ml methanol, 6 ml Milli-Q water in order.  Samples were then 
loaded and the cartridges were allowed to dry under vacuum. Cartridges were 
stored at -20°C until elution and analysis.   
 Cartridges were eluted with methanol/1% acetic acid and stored in 
sample vials for HPLC analysis.  The HPLC consisted of a Water 1525 Breeze 
HPLC Pump with a Water 717 Plus auto sampler and a Waters 2475 multi 
wavelength fluorescence detector (Waters, Milford, MA, USA).  The mobile 
phase consisted of 40 parts HPLC grade acetonitrile: 60 parts Milli-Q water, pH 
adjusted to 3.0 with glacial acetic acid: 4 parts triethylamine. The mobile phase 
was filtered through a 0.2 µm nylon filter and degassed using a sonication bath.  
The flow rate was set at 1 ml/min and a 40 µl injection volume was used.  A 
Varian Polaris C-18A reverse phase analytical column (250 mm long, 4.6 mm 
I.D.) was used to achieve chromatographic separation.  The fluorescence 
detector was set at excitation wavelength 270nm and emission wavelength 
300nm.  Run times were approximately 12 minutes per sample.   
Brain Tissue Preparation 
 Bass were euthanized after each feeding event by immersion in MS-222 
until opercular movement ceased.  Brains were quickly removed and stored at -
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80°C until processing.  For monoamine analysis via HPLC brains were weighed 
and 1 mL of 0.1N perchloric acid was added to the sample container.  Samples 
were sonicated at 20% amplitude for 10 seconds with a Branson Sonifier (model 
S-450) probe sonicator (Emerson Electric Co, Danbury, CT, USA).  Samples 
were then centrifuged at 25,000 RPM (57,000 G) for 25 minutes at 4°C to 
remove cellular debris.  Supernatant was removed and placed in a 1.5 mL 
microcentrifuge tube and centrifuged again at 17,000G for 15 minutes to ensure 
complete removal of debris.  A 200 µL aliquot was taken from the supernatant 
and spiked with 50 ppb DHBA (internal standard).  Samples were stored at -80C 
until analysis.  Another 5 µL aliquot was taken from the supernatant and diluted 
in 20 µL of 0.1N perchloric acid for protein concentration analysis.   
Protein Concentration Analysis 
 Brain protein concentrations were measured using a BCA™ Protein Assay 
Kit (Pierce, Rockford, IL, USA).  Aliquots from brain extracts were diluted 1:4 in 
0.1N perchloric acid before analysis.  Brain monoamine concentrations were 
normalized to protein concentrations.   
Monoamine Analysis 
 Brain samples were analyzed for serotonin (5-HT), dopamine (DA), 
norepinephrine (NE), 5-HIAA, and DHBA via HPLC with an electrochemical 
detector using a method modified from Lin and Pivorun [35].  The 
chromatographic system consisted of a Rainin Rabbit HPX HPLC pump, with a 
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Bioanalytical Systems LC-4C amperometric detector.  Chromatographic 
separation was achieved with an ODS-2 Hypersil 250mm x 4.6 mm C18 reverse 
phase analytical column (Fisher Scientific, Pittsburgh, PA).  Aliquots of 50 µL 
were injected into a 20 µL sample loop of a rotary injection valve.  The flow rate 
was set to 1.0 mL/min and the electrode potential was maintained at +0.8 volts 
vs. Ag/AgCl.  Sample run times were approximately 29 minutes. 
 The mobile phase consisted of 14.2 g monochloroacetic acid, 4.7 g 
sodium hydroxide, 10.0 mg disodium EDTA, 150 mg sodium octyl sulfate 
dissolved in 967 mL of Milli-Q water with 15 mL of methanol and 18 mL of 
tetrahydrofuran.  The mobile phase was filtered through a 0.45 µm nylon filter 
(Millipore™, Billerica, MA, USA) and degassed via sonication bath before use. 
Data Analysis 
Time to capture prey was analyzed using Statistical Analysis Software 9.2 
(SAS, Cary, NC, USA).  A general linear means for mixture distributions (PROC 
GLIMMIX) procedure was used to perform a two factor ANOVA utilizing 
treatment and day as independent variables and tank as a random variable.  The 
time to capture prey data were non-normally distributed with non-homogenous 
variances.  The GLIMMIX procedure uses an analysis matrix that accounts for 
non-normal distribution and non-homogenous variances in data points.   Least 
squared means was used to perform multiple pairwise comparisons of data and 
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differentiate statistical differences across and within treatment, day, and 
treatment by day interactions.   
Brain monoamine data also exhibited non-homogenous variances, 
therefore the general linear means for mixture distributions was used to perform 
a two factor ANOVA utilizing treatment and day as independent variables and 
tanks as a random variable.  Least squared means was used to perform multiple 
pairwise comparisons of data and differentiate statistical differences across and 
within treatment, day, and treatment by day interactions. 
Results 
Water Quality Measurements 
Water quality measurements were averaged for the entire test.  pH, 
dissolved oxygen, and temperature were (mean ± standard deviation) 6.51 ± 
0.35, 8.27 mg/L ± 0.48, and 24.39°C ± 1.04, respect ively. 
Antidepressant Concentrations 
The average concentration (mean ± standard deviation) over the entire 
test for one, two, and four TU treatments were 10.81 ± 1.36, 23.84 ± 2.63, and 
55.47 ± 8.72 µg/L, respectively for fluoxetine and 15.50 ± 2.02, 32.43 ± 3.21, and 
74.30 ± 11.32 µg/L, respectively for venlafaxine. 
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Behavioral Assays 
 Complete numerical results from behavioral assay are presented in the 
appendix Table A-4.  The time for hybrid striped bass to capture their first prey is 
presented in Figure 4.1.  There was a statistically significant increase (p<0.05) in 
the time to capture prey one for the highest treatment when compared to controls 
on day three.  By day six of exposure the one and four toxic unit mixtures 
showed a significant increase in time to capture prey.  Though the two toxic unit 
mixture appear to be increased the value was not statistically significant with a p 
value of 0.06.  The one and two toxic unit treatments were able to recover to 
control levels by day nine (day three of depuration) and stayed at control levels 
through day twelve (sixth day of depuration).  The four toxic unit treatment 
remained elevated over controls even after a six day depuration period. 
 The time to capture prey two is presented in Figure 4.2.  The two and four 
toxic unit mixtures caused a significant increase in the time to capture prey two 
by day three of exposure.  By day six of exposure all three treatments caused a 
significant increase in the time to capture prey two.  By day nine (three days of 
depuration) the one and two toxic unit treatments had returned to control levels 
while the four toxic unit treatment remained significantly increased over controls.  
On day twelve the one toxic unit treatment became significantly elevated over 
controls while the two and four toxic unit treatments were not significant.  It is 
important to note that the four toxic unit treatment appeared elevated over 
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controls but was not statistically significant on day twelve.  This may be due to 
low replication and high variability on this day.  
 The time to capture prey three for hybrid striped bass exposed to 
venlafaxine for six days is presented in Figure 4.3.  All toxic unit mixtures were 
significantly increased over controls on day three and six of exposure.  The two 
and four toxic unit mixtures remained significantly elevated over controls after 
three days of depuration (day nine).  After six days of depuration (day twelve) the 
one toxic unit was once again significantly elevated over controls while the four 
toxic unit was no longer significant.  Once again appears that the four toxic unit 
treatments are elevated over controls but they were not significant due to low 
replication and high variability.    
The time to capture prey four data are not presented graphically as they 
were highly variable for both treatments and controls.  Therefore, there were no 
statistically significant increases in time to capture prey in treatments when 
compared to controls. 
Qualitative Behavioral Observations 
 Similar to previous studies with venlafaxine and fluoxetine, a number of 
qualitative behavioral traits were observed in the highest treatment (four toxic unit 
mixture).  Some of the observations included spitting out prey fish, trouble 
swallowing prey, maintaining a vertical position in the water column, erratic 
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swimming, swimming with dorsal surface out of the water, and gulping for air at 
the surface.  
Brain Chemistry 
Concentrations of norepinephrine and dopamine in the brains of bass 
exposed to mixtures of fluoxetine and venlafaxine for six days are presented in 
Figures 4.4 and 4.5, respectively.  There were no dose-dependent trends for 
either of these neurotransmitters for the exposure or recovery period.   
Brain serotonin concentrations were significantly decreased by day three 
of exposure (Figure 4.6).  Serotonin concentrations remained at this apparent 
basal level through the end of exposures on day six.  Following three days of 
depuration (day nine) the one toxic unit mixture treatment returned to control 
levels while the two and four toxic unit mixtures remained significantly decreased 
when compared to controls.  After six days of depuration (day twelve) all 
treatments had returned to control levels. 
The primary metabolite of serotonin, 5-HIAA, followed the same trends as 
serotonin in the brains of exposed bass (Figure 4.7).  Metabolite concentrations 
reached a significantly decreased basal level by day three of exposure and 
remained decreased through the end of exposure on day six.  After three days of 
depuration the one toxic unit mixture treatment returned to control levels while 
the two and four toxic unit mixtures remained significantly decreased.  By the 
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sixth day of depuration all treatments had returned to control levels.  (Numerical 
results for 5-HT and 5-HIAA are presented in the appendix Table A-5) 
The 5-HIAA/5-HT ratio for hybrid striped bass exposed to mixtures of 
fluoxetine and venlafaxine is presented in Figure 4.8.  There were no significant 
changes in this ratio for the exposure or recovery periods.   
Brain Chemistry/Behavior Relationship 
 Because serotonin was the only neurotransmitter measured to show a 
significant trend over the exposure and recovery periods, relationships between 
mixture concentrations, behavioral results, and serotonin concentrations were 
examined.  There was a linear relationship among toxic unit treatments and brain 
serotonin concentrations as seen in Figure 4.9.  This was not surprising as brain 
serotonin concentrations quickly reached a basal level for all exposure scenarios 
by the third day of exposure.  There was an exponential relationship between 
brain serotonin concentrations and the time to capture prey on day 6 (Figure 
4.10). Overall, the data indicate that mixtures of the antidepressants fluoxetine 
and venlafaxine cause an exponential decrease in brain serotonin concentrations 
which coincides with increased time to capture prey one and two on day six.   
Mixtures vs. Individual Compounds 
Predictions for 1:1 additivity for percent serotonin decrease were 
generated from the percent decrease in serotonin concentrations from controls 
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caused by one toxic unit (23 µg/L fluoxetine [21], 35 µg/L venlafaxine [22]) for 
each individual antidepressant.  For example, the one toxic unit mixture had half 
the concentration of one toxic unit of each individual antidepressant (15 µg/L 
fluoxetine, 25 µg/L).  Therefore, we predicted that if fluoxetine and venlafaxine 
were strictly additive, the percent serotonin decrease for the one toxic unit 
mixture would be the sum of half the percent serotonin decrease of one toxic unit 
from the individual antidepressant exposures. The percent decrease in brain 
serotonin concentrations from mixtures were then compared to predicted values.  
If predicted values fell within the standard deviation of the mean for mixtures, that 
specific mixture was considered additive.  If the predicted values were higher 
than the standard deviation of the mean the mixture was considered less than 
additive.  The data (Table 4.1) showed that on day three the percent decrease in 
brain serotonin was additive for the one and two toxic unit mixtures but less than 
additive for the four toxic unit mixture.  On day six only the one toxic unit mixture 
was shown to be additive.   
Time to capture prey one, two, and three from one toxic unit of each of the 
individual antidepressant was used to predict effects of antidepressant mixtures 
on hybrid striped bass predation behavior (Table 4.2).  Calculations were made 
in similar fashion to brain serotonin predictions with the one toxic unit mixture 
receiving half the effect of one toxic unit of each individual compound.  If 
predicted time to capture prey was within the standard error of the mean for each 
mixture that mixture was considered to act in an additive manner.  On day three, 
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all three mixture treatments showed additive effects on the time to capture prey 
one while none of the mixture treatments caused additive effects for prey two and 
three.  On day six only the one toxic unit treatment caused additive effect, but 
this effect was seen for prey one, two, and three.   
Overall the data showed that low concentration (one toxic unit) mixtures 
act in a predictively additive manner on brain serotonin concentrations and 
predation behavior.  Higher concentration mixtures (two, four toxic units) did not 
have the predicted effect on brain chemistry due to brain serotonin 
concentrations reaching an apparent basal threshold level.  These mixtures also 
did not have an additive effect on time to capture prey.   
Discussion 
 A number of studies have shown that antidepressants are present in 
complex mixtures in the environment [1-6].  But characterization of the toxicity of 
these mixtures is difficult because the contribution of individual compounds is 
largely unknown.  Also, interactions between chemicals in vivo are unpredictable 
in most cases.  The objective of the current study was to examine a simple 
mixture of antidepressants whose effects have previously been characterized 
individually. 
 Hybrid striped bass exposed to mixtures of fluoxetine and venlafaxine 
exhibited similar effects on predation behavior to those previously reported for 
the individual compounds.  In general there was a dose dependent increase in 
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time to capture prey one, two, and three on the third day with more treatments 
becoming significant with each additional prey.  But on day six, the time to 
capture prey one for the two toxic unit treatment was no longer significant when 
compared to controls.  The p-value was close to significant (0.06) and 
insignificance was probably due to high variability for this treatment on this day.  
This is further evidenced by all treatments causing significant increases in time to 
capture prey two and three on day six. 
During the recovery period, the one and two toxic unit mixture treatments 
were able to recover by day nine but the one toxic unit treatments were 
increased over controls again on day twelve.  The highest treatment (four toxic 
units) remained significantly increased when compared to controls throughout the 
recovery period.  Insignificance on day twelve for prey two and three was due to 
high variability and low replication on these days.  The recovery results were 
similar to recovery periods for individual exposures to fluoxetine and venlafaxine.  
Bass exposed to 100 µg/L fluoxetine for six days were unable to recovery their 
ability to capture prey after a six day recovery period [21].   Similarly, bass 
exposed to venlafaxine at concentrations of 465 µg/L for six days were also 
unable to recover their ability to capture prey after a six day recovery period. 
Venlafaxine is designed to inhibit the transport of both norepinephrine and 
serotonin but there was only one day and one treatment when norepinephrine 
differed significantly from controls (Figure 4.4).  Our previous study that exposed 
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bass to higher concentrations of venlafaxine showed similar lack of effect on 
norepinephrine [22].  While venlafaxine is marketed as a serotonin and 
norepinephrine reuptake inhibitor, it has an order of magnitude lower affinity for 
the norepinephrine transporter when compared to the serotonin transporter in 
mammalian systems [36].  This translates into needing an order of magnitude 
higher concentration of venlafaxine to have a similar effect on norepinephrine as 
seen on serotonin.  Therefore, it was not surprising that there was no effect on 
norepinephrine in this study. 
Serotonin concentrations reached a basal level for all mixture exposure 
treatments by day three and remained decreased through day six (Figure 4.6).  
When comparing mixture exposure serotonin concentrations to individual 
exposure serotonin concentrations there was an interesting difference between 
day three and six.  Our previous work showed that fluoxetine caused decreases 
in serotonin levels in a dose dependent manner [21].   Venlafaxine eventually 
caused serotonin to decrease to a threshold level regardless of treatment, but 
serotonin initially decreased in a dose dependent manner [22].   Results from the 
current study showed that serotonin concentrations reached an apparent basal 
level by day three marking a much faster decrease than the previous study 
(Figure 4.6).  This immediate decrease to basal threshold levels for serotonin 
correlated well with the increased time to capture prey discussed above (Figure 
4.10).  Selective serotonin reuptake inhibitor antidepressants have been reported 
to decrease brain serotonin concentrations in hybrid striped bass [21], betta 
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splendens [37], and rats [38].  To our knowledge, our previous work with 
venlafaxine [22] and the current study are the only examples that demonstrate 
antidepressants causing serotonin to reach basal threshold levels.   
Analysis of the additive effect of antidepressant mixtures revealed that low 
concentration mixtures caused additive decreases in brain serotonin 
concentrations on day three and day six (Table 4.1).   But higher concentrations 
did not cause an additive effect.  The same phenomenon was seen when 
comparing the time to capture prey to predictive additivity based on individual 
exposure effects (Table 4.2).  Low concentration mixtures caused additive effects 
on the time to capture all prey by day six.  These data indicate that once 
serotonin reaches its apparent basal threshold level, the capacity for effects 
increasing in an additive manner is diminished.  There is also evidence in the 
literature of lower concentrations of antidepressants and antidepressant mixtures 
having significant effect when higher concentrations have no effect.  Embryonic 
exposures to low concentrations of venlafaxine (500 ng/L) caused significant 
effects on escape latency behavior and total escape response while higher 
exposure concentrations did not cause any effects.   After larval exposures to low 
concentrations of antidepressant mixtures, significant effects were seen on 
escape velocity and total escape response while higher concentration mixtures 
had no effect [18].  Low concentration exposure to venlafaxine caused significant 
mortality when compared to controls in exposed adult fathead minnows while 
higher concentrations caused less of an effect [34].  
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While we did not see additive effects for the two higher mixture exposures, 
we saw effects on brain serotonin and time to capture prey extend into the 
recovery period.  Therefore, it appears that although brain serotonin 
concentrations did not decrease any further with higher mixture exposures, these 
exposures caused longer lasting effects even after exposure ceased.  Serotonin 
has been implicated in controlling a number of physiological functions in fish both 
directly and indirectly [39].  Direct control can be achieved through modulation of 
serotonin in the brain as well as other organs that play a role in appetite and 
behavior.  Serotonin containing neurons have been found in the enteric 
(gastrointestinal) nervous system of fish [40] and play a role in gut motility, which 
can influence appetite [41].  Serotonin containing cells have also been found in 
the pineal gland of fish, an organ that plays a role in behavioral and physiological 
functions [42].  Serotonin can indirectly affect downstream processes by 
controlling the release of hormones and peptides such as gonadotropin, growth 
hormone [43], cortisol [44-46], and corticotropin-releasing factor [47].  Therefore, 
it is possible that serotonin returned to control levels by day twelve in the brains 
of fish for the highest mixture treatment, but an unknown downstream response 
in other organs and hormones regulated by serotonin, may have continued to 
increase time to capture prey after depuration.     
Though research on the effects of pharmaceutical mixtures is fairly limited, 
comparison of our results to the body of research on the toxicity of mixtures of 
other endocrine disruptors reveals that the results of this study are consistent 
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with previously shown additivity concepts.  Normalizing mixture exposure 
concentrations to specific effect level was effective in predicting the additive 
effects of antidepressants in the current study.  The same method has been 
successfully used to examine the effects of mixtures of polychlorinated biphenyls 
(PCBs), polychlorinated dibenzodioxins (PCDDs), and polychlorinated 
dibenzofurans (PCDFs) [27].  The development of estradiol equivalency factors 
has also been used to predict the additive effects of estrogenic mixtures in fish 
[31].  The same method has also been successfully employed for anti-androgens 
and thyroid-disrupting compounds [24].  The current study was also able to 
exemplify one of the underlying theories of the dose addition concept, which is 
that high concentration mixtures will not cause consistently increasing effects on 
a measured endpoint due to saturation of effects on molecular targets [24].   
The similarities in the additivity of antidepressants in the current study and 
additivity of mixtures of other endocrine disrupting compounds in the literature, 
suggests that antidepressant mixtures present a significant risk to our 
environment.  The current study showed that low concentrations of 
antidepressants act in an additive manner on fish brain chemistry and behavior.  
Therefore, pursuit of a more robust mixture exposure scenario may reveal that 
antidepressant mixtures at currently measured concentrations can produce 
additive effects that pose a significant risk to aquatic organisms.  Development of 
a serotonin depression index of antidepressants may also assist in the prediction 
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of the effects of antidepressant mixtures found in the receiving waters of waste 
water treatment plant effluent.      
Behavior plays a role in a number of daily activities that aquatic organisms 
must perform to survive.  Effects on behavior can have a direct impact on 
organism fitness through disruption of feeding or predator avoidance.  
Reproduction in aquatic organisms often involves complex mating behaviors or 
displays that must be performed for individuals to contribute their genes to the 
next generation.  Disruption of these behaviors can also indirectly impact an 
entire population in a negative way.  Therefore, it is important to understand how 
contaminants that may not directly affect survival can impact sensitive behavioral 
traits.  The results of the current study indicate that low concentration 
antidepressant mixtures have an additive effect on brain chemistry and behavior 
at an accelerated rate when compared to individual compounds.  Therefore, 
these compounds present a significant risk and need to be further investigated.  
Conclusions 
Overall results from the current study indicate that antidepressant mixtures 
cause an immediate decrease in brain serotonin concentrations to an apparent 
basal level.  Decreases in brain serotonin in turn caused an exponential increase 
in time to capture prey.  Examination of brain serotonin concentrations and time 
to capture prey data for organisms exposed to antidepressant mixtures 
compared to those organisms exposed only to individual antidepressants 
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suggest that low concentration mixtures act in a predictively additive manner.  
Additive effects were unable to be predicted for higher concentrations mixtures, 
which could be expected due to the saturation of serotonin depression in the 
brains of exposed fish.  The antidepressant mixtures in the current study acted in 
a similar manner to mixtures of other endocrine disrupting compounds 
suggesting that antidepressant mixtures present a significant risk to aquatic 
organisms. 
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Figure 4.1: Time to capture prey 1 for hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine.  
Time to capture prey 1 for hybrid striped bass exposed mixtures of fluoxetine and venlafaxine for 6 days and 
allowed to recover for 6 days.  Treatments were 0, 1, 2, 4 toxic units.  Asterisks represent statistical significance 
when compared to control.  Error bars represent ±1 standard error.  
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Figure 4.2: Time to capture prey 2 for hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine.  
Time to capture prey 2 for hybrid striped bass exposed mixtures of fluoxetine and venlafaxine for 6 days and 
allowed to recover for 6 days.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical 
significance when compared to control.  Error bars represent ±1 standard error. 
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Figure 4.3: Time to capture prey 3 for hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine.  
Time to capture prey 3 for hybrid striped bass exposed mixtures of fluoxetine and venlafaxine for 6 days and 
allowed to recover for 6 days.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical 
significance when compared to control.  Error bars represent ±1 standard error. 
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Figure 4.4: Brain norepinephrine concentrations in hybrid striped bass exposed to mixtures of fluoxetine 
and venlafaxine for 6 days. 
Brain norepinephrine concentrations for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical significance when 
compared to control on that day.  Error bars represent ±1standard deviation. 
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Figure 4.5: Brain dopamine concentrations in hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine for 6 days.  
Brain dopamine concentrations for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical significance when 
compared to control on that day.  Error bars represent ±1standard deviation. 
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Figure 4.6: Brain serotonin concentrations in hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine for 6 days. 
Brain serotonin concentrations for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day 
recovery period.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical significance when 
compared to control on that day.  Error bars represent ±1standard deviation.  
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Figure 4.7: Brain 5-HIAA concentrations in hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine for 6 days.  
Brain 5-HIAA concentrations for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day recovery 
period.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical significance when compared to 
control on that day.  Error bars represent ±1standard deviation.  
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Figure 4.8: Brain 5-HIAA/5-HT ratios in hybrid striped bass exposed to mixtures of fluoxetine and 
venlafaxine for 6 days.  
Brain 5-HIAA/5-HT ratios for hybrid striped bass exposed to venlafaxine for 6 days followed by a 6 day recovery 
period.  Treatments were 0, 1, 2, and 4 toxic units.  Asterisks represent statistical significance when compared to 
control on that day.  Error bars represent ±1standard deviation. 
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Figure 4.9: Brain serotonin concentrations as a function of mixture concentrations. 
Brain serotonin concentrations as a function of mixture concentrations in toxic units on days 3 and 6.  Curves were 
fit using a logarithmic equations displayed below the curve for day 3 and above the curve for day 6.  Correlation 
coefficients are displayed for the respective equations.  
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 Figure 4.10: Time to capture prey as a function of brain serotonin levels on day 6. 
Time to capture prey 1 and 2 for hybrid striped bass exposed to venlafaxine for 6 days as a function of brain 
serotonin concentrations.  Curves were fit using exponential equations.  Respective equations and correlation 
coefficients are displayed above and below curves. 
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Table 4.1: Additivity analysis based on 1:1 additivity predicted from % serotonin decreases as a result of 
individual antidepressant exposures 
 
Treatment Fluoxetine  Venlafaxine  Mixtures Predicted 1:1 
Day (Toxic Units) (% decrease) (% decrease) (mean ± SD) Additivity Additive? 
3 
1 13.57 15.28 34.37 ± 16.21 14.42 Additive 
2 29.67 ± 9.60 28.85 Additive 
4 26.87 ± 14.54 57.69 < Additive 
 
6 
1 13.52 36.74 25.95 ± 10.16 25.13 Additive 
2 22.65 ± 10.34 50.26 < Additive 
4     27.69 ± 8.62 100.52 < Additive 
 
Percent decrease in serotonin when compared to controls data from individual exposures to fluoxetine [21] and 
venlafaxine [22] are used to predict 1:1 additivity of antidepressant mixtures.  Serotonin data for fluoxetine were 
from 23.2 ± 6.6 µg/L (mean ± SD) exposures and 35.68 ± 6.75 µg/L exposures for venlafaxine. Mixtures were 
determined to be additive if the predicted additivity fell within the standard error of the mean for each mixture. 
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Table 4.2: Additivity analysis based on 1:1 additivity of time to capture prey 
data from individual antidepressant exposures 
A 1 Toxic Unit  Predicted 1:1 Fluoxetine  Venlafaxine  mean ± SE Additivity 
Day Prey (seconds) (seconds) (seconds) for 1 toxic unit Additive? 
3 
1 50.79 175.43 99.9 ± 74.94 113.11 additive 
2 414 340 182 ± 101.262 377 < additive 
3 772 714.57 549.45 ± 160.15 743.285 < additive 
6 
1 397 135.56 410 ± 160.69 266.28 additive 
2 575.25 501.83 616.07 ±192.95 538.54 additive 
3 1256.92 942.94 866.87 ± 184.02 1099.93 additive 
B 2 Toxic Unit  Predicted 1:1 Fluoxetine  Venlafaxine  mean ± SE Additivity 
Day Prey (seconds) (seconds) (seconds) for 2 toxic unit Additive? 
3 
1 50.79 175.43 232.5 ± 102.70 226.22 additive 
2 414 340 475.59 ± 137.90 754 < additive 
3 772 714.57 661.59 ± 143.77 1486.57 < additive 
6 
1 397 135.56 294.13 ± 140.38 532.56 <additive 
2 575.25 501.83 428.29 ± 150.76 1077.08 <additive 
3 1256.92 942.94 723.29 ± 169.16 1500 <additive 
C 4 Toxic Unit  Predicted 1:1 Fluoxetine  Venlafaxine  mean ± SE Additivity 
Day Prey (seconds) (seconds) (seconds) for 4 toxic unit Additive? 
3 
1 50.79 175.43 588.18 ± 151.97 452.44 additive 
2 414 340 646.45 ± 144.72 1500 < additive 
3 772 714.57 1054.2 ± 134.31 1500 < additive 
6 
1 397 135.56 638.41 ± 180.46 1065.12 <additive 
2 575.25 501.83 821.24 ± 180.27 1500 <additive 
3 1256.92 942.94 1191.4 ± 132.98 1500 <additive 
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Time to capture prey data from individual exposures to fluoxetine [21] and 
venlafaxine [22] are used to predict 1:1 additivity of antidepressant mixtures.  
Time to capture prey data for fluoxetine are from 23.2 ± 6.6 µg/L (mean ± SD) 
exposures and 35.68 ± 6.75 µg/L exposures for venlafaxine. 1, 2, and 4 toxic unit 
mixtures are compared in panels A, B, and C respectively.  Mixtures were 
determined to be additive if the predicted additivity fell within the standard error of 
the mean for each mixture.   
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CHAPTER FIVE: 
OVERALL CONCLUSIONS 
Effects of long term exposure to fluoxetine on hybrid striped bass behavior 
1.  Long term exposure to fluoxetine did not decrease the toxic threshold of 
effect when compared to short term exposures. 
2. Six day exposures are sufficient to examine the behavioral toxicity of 
fluoxetine 
Effects of venlafaxine on the brain chemistry and behavior of hybrid striped 
bass 
1.  Venlafaxine caused an initial dose dependent decrease in brain serotonin 
concentrations of exposed hybrid striped bass and eventually caused a 
depression of serotonin to an apparent basal threshold level for all 
treatments. 
2. Venlafaxine increased time to capture all prey for hybrid striped bass 
exposed at concentrations of 250 and 500 µg/L.  The lowest concentration 
tested, 50 µg/L, only increased the time to capture prey 3. 
3. At low concentrations venlafaxine appears to affect appetite while higher 
concentrations may also affect locomotor function 
4. Brain serotonin concentrations were not predictive of changes in predation 
behavior 
 157 
 
5. The differential behavioral toxicity of fluoxetine and venlafaxine can be 
explained by the higher affinity of fluoxetine for the serotonin transporter 
when compared to venlafaxine.  
Effects of mixtures of fluoxetine and venlafaxine on brain chemistry and 
behavior of hybrid striped bass 
1.  Antidepressant mixtures caused a decrease in brain serotonin 
concentrations to an apparent basal threshold level for all treatments by 
day 3. 
2. Time for bass to capture their prey was significantly affected by all 
antidepressant mixtures by day 6. 
3. Low concentration mixtures acted in an additive manner on brain 
serotonin concentrations and time to capture prey while higher 
concentrations were less than additive. 
4. The lack of additivity in higher concentration mixture treatments may be 
due to saturation of the antidepressant effects on serotonin transporters. 
Examination of the behavioral effects of antidepressants is an ecologically 
relevant endpoint due to the unique mode of action of these chemicals.    The 
results of my dissertation showed that use of this endpoint can provide insight 
into the potential sublethal effects of antidepressants that may not be captured 
during traditional toxicity testing.  Our laboratory has now shown that two 
different antidepressants, fluoxetine and venlafaxine, cause significant effects on 
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the brain chemistry and behavior of hybrid striped bass.  Low concentration 
mixtures of these two compounds were also shown to have additive effects on 
these endpoints.  Therefore, the presence of low concentration mixtures of 
antidepressants in the environment may cause significant effects on fish 
behavior.  Behavior can both directly and indirectly affect fish fitness and 
ultimately population health.  As a result, inclusion of behavioral endpoints may 
be essential for the assessment of risk that antidepressants pose to aquatic 
organisms to ensure adequate protection of populations. 
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APPENDIX  
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Table A-1: Time for hybrid striped bass exposed to fluoxetine to capture their prey 
 
Prey  Treatment Day 0 Day 3 Day 6 Day 9 Day 12 Day 15 Day 18 Day 21 Day 24 Day 27 
Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE 
1 Control 6.05 2.24 8.21 3.93 29.16 18.11 11.71 9.10 29.64 15.61 57.20 48.95 193.00 161.10 2.60 0.24 12.00 8.75 7.00 3.16 
10 µg/L 8.32 2.34 55.26 36.06 106.26 80.30 123.07 106.16 129.36 106.12 248.00 168.48 256.33 162.01 13.40 4.82 35.40 23.46 128.20 91.17 
20 µg/L 4.35 1.00 14.06 5.51 125.53 89.28 129.85 114.26 443.46 187.77 17.63 8.52 195.50 186.37 71.50 39.07 753.50 495.84 759.50 495.01 
30 µg/L 5.37 1.39 250.63 127.62 318.16 128.52 33.57 14.60 387.86 162.24 54.67 19.26 39.78 13.07 6.50 2.84 4.00 2.12 96.75 94.42 
40 µg/L 3.25 0.85 47.81 19.93 338.31 146.93 446.09 193.65 539.27 213.65 501.25 237.00 498.38 226.18 212.33 152.04 516.00 492.09 520.67 489.86 
2 Control 14.95 5.02 61.26 45.68 119.53 81.24 33.57 25.14 81.64 41.15 105.80 79.98 175.50 147.54 5.20 0.97 55.80 40.08 316.60 295.90 
10 µg/L 21.68 5.28 219.32 108.86 169.79 107.57 217.93 119.18 227.50 118.34 488.89 206.65 504.67 212.03 36.60 8.69 175.40 139.85 366.00 285.93 
20 µg/L 10.24 1.86 284.24 140.82 353.59 140.20 277.08 143.82 593.77 206.89 226.50 120.24 402.13 239.91 296.50 46.77 765.00 486.37 764.50 489.50 
30 µg/L 14.58 3.72 274.26 125.90 559.05 155.39 229.86 110.34 527.64 161.03 256.44 157.87 149.78 53.36 55.50 48.17 383.25 372.28 106.00 93.68 
40 µg/L 12.63 3.45 122.81 44.84 612.88 168.99 564.82 209.78 773.64 216.18 856.88 247.44 710.50 241.20 762.33 375.55 1500.00 0.00 1500.00 0.00 
3 Control 22.79 6.36 117.53 77.47 331.58 142.28 210.43 115.43 319.71 143.76 294.10 157.39 209.60 145.18 364.00 285.27 485.80 267.71 646.00 348.79 
10 µg/L 76.26 28.57 334.68 127.97 343.58 141.26 408.36 160.87 621.79 183.50 719.67 210.79 787.89 233.49 339.60 160.34 651.40 348.83 406.60 277.36 
20 µg/L 21.88 4.28 482.47 165.07 649.47 178.23 619.46 201.37 699.77 192.09 543.25 228.96 446.38 231.73 1485.00 10.00 800.00 466.67 1500.00 484.00 
30 µg/L 32.89 7.92 513.68 158.82 923.74 159.21 712.79 178.80 833.29 189.29 461.78 202.87 754.44 227.60 627.00 356.01 761.75 426.24 148.75 122.83 
40 µg/L 101.06 72.72 629.31 177.44 1004.06 169.56 1007.00 207.50 987.64 215.01 1083.13 229.38 1151.00 228.53 1447.33 52.67 1500.00 0.00 1500.00 0.00 
4 Control 222.26 90.36 380.00 139.43 540.37 148.20 536.57 176.76 709.36 194.84 1108.80 200.67 377.20 145.25 1002.80 310.59 1500.00 0.00 1001.80 307.90 
10 µg/L 312.21 90.75 571.47 150.22 590.47 164.34 1060.00 155.95 1163.29 148.44 1027.11 195.53 1150.11 166.37 930.00 349.15 990.80 319.76 1008.40 310.15 
20 µg/L 113.29 46.50 768.41 174.05 947.12 167.87 831.54 194.46 986.85 188.04 1145.75 174.36 1146.63 231.81 1500.00 0.00 1500.00 0.00 1500.00 471.00 
30 µg/L 65.21 18.15 846.74 163.19 1304.26 108.15 1293.00 120.50 1237.79 140.14 1262.00 120.37 924.00 229.26 1230.50 269.50 957.00 313.52 230.00 102.96 
  40 µg/L 204.81 84.62 867.69 177.82 1318.13 124.26 1264.09 160.43 1351.82 121.26 1378.50 121.50 1237.63 178.89 1500.00 0.00 1500.00 0.00 1500.00 0.00 
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Time for hybrid striped bass to capture four consecutive prey during exposure to fluoxetine for 27 days.  Values are 
presented as means ± standard error.  Data are presented graphically in figure 2.1, 2.2, and 2.3.  Concentrations of 
10, 20, 30, and 40 µg/L were measured at (mean ± SD) 9.949 ± 1.495, 18.59 ± 3.513, 27.42 ± 3.186, and 41.17 ± 
5.506 µg/L, respectively. 
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Table A-2: Time for hybrid striped bass exposed to venlafaxine to capture their prey 
Prey  Treatment Day 0 Day 3 Day 6 Day 9 Day 12 
Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE 
1 Control 6.22 2.35 71.70 64.95 21.89 8.43 7.60 4.55 19.40 13.47 
50 µg/L 7.74 1.95 175.43 87.84 135.56 82.87 337.80 195.91 6.80 2.11 
250 µg/L 8.39 3.05 602.91 143.08 931.06 159.25 532.89 242.52 163.80 157.56 
500 µg/L 6.16 1.31 336.95 133.33 833.86 177.61 397.38 240.73 116.20 107.97 
2 Control 17.17 5.57 230.70 98.06 200.72 112.04 155.20 149.43 33.00 22.93 
50 µg/L 13.91 3.02 340.00 118.13 501.83 155.99 612.90 241.49 111.00 58.58 
250 µg/L 25.35 10.77 817.39 129.89 1299.33 109.89 728.11 246.75 589.20 330.89 
500 µg/L 14.47 3.58 754.21 157.47 1083.36 161.46 427.00 235.07 571.80 333.13 
3 Control 52.43 16.92 402.00 127.93 372.94 134.87 310.70 198.24 213.00 177.60 
50 µg/L 70.09 29.66 714.57 148.06 942.94 154.87 902.70 241.30 912.40 359.87 
250 µg/L 47.00 17.08 1166.00 123.68 1372.17 87.82 1067.56 217.66 709.40 324.92 
500 µg/L 33.32 10.05 1019.64 122.26 1182.60 120.61 977.63 255.41 932.80 347.70 
4 Control 328.30 103.96 615.70 143.27 670.50 162.09 528.80 213.77 485.00 269.64 
50 µg/L 395.04 121.32 1005.35 133.84 1236.67 104.62 924.60 235.58 916.20 357.52 
250 µg/L 355.22 106.40 1283.96 105.62 1435.89 64.11 1223.89 184.39 1033.60 289.89 
  500 µg/L 244.68 88.84 1225.74 119.29 1500.00 0.00 1193.88 203.16 959.80 332.30 
 
 
Time for hybrid striped bass to capture four consecutive prey during 6-day exposures to venlafaxine followed by a 6 
day recovery period.  Values are presented as means ± standard error.  Data are presented graphically in figure 
3.2, 3.3, and 3.4.  Concentrations of 50, 250, and 500 µg/L were measured at (mean ± SD) 35.68 ± 6.75, 198.67 ± 
22.21, and 465.39 ± 43.68 µg/L, respectively. 
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Table A-3: Brain serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations for hybrid 
striped bass exposed to venlafaxine 
Prey  Treatment Day 0 Day 3 Day 6 Day 9 Day 12 
Mean ±SD Mean ±SD Mean ±SD Mean ±SD Mean ±SD 
5-HT Control 166.81 26.31 144.22 24.98 123.24 23.40 130.60 28.74 150.24 37.95 
50 µg/L 166.81 26.31 122.65 41.68 77.94 23.40 88.96 11.71 110.40 7.26 
250 µg/L 166.81 26.31 113.64 65.77 78.95 10.01 89.55 8.00 164.92 38.02 
500 µg/L 166.81 26.31 71.08 19.59 84.70 16.12 70.27 15.74 132.56 29.47 
5-HIAA Control 87.37 11.83 82.06 10.27 68.63 17.29 50.28 9.50 72.93 12.29 
50 µg/L 87.37 11.83 62.13 17.27 46.29 14.75 29.50 2.80 57.34 3.75 
250 µg/L 87.37 11.83 52.97 10.75 52.27 5.58 35.74 6.08 69.93 22.84 
  500 µg/L 87.37 11.83 48.23 12.64 27.90 8.11 26.80 2.46 55.00 15.92 
 
Concentrations of 5-HT and 5-HIAA (pg/µg protein) in the brains of hybrid striped bass exposed to venlafaxine for 6 
days followed by a 6 day recovery period.  Values are presented as a mean ± standard deviation.  Data are 
presented graphically in figures 3.7 and 3.8.  Concentrations of 50, 250, and 500 µg/L were measured at (mean ± 
SD) 35.68 ± 6.75, 198.67 ± 22.21, and 465.39 ± 43.68 µg/L, respectively. 
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Table A-4: Time for hybrid striped bass exposed to mixtures of fluoxetine (FLX) and venlafaxine (VEN) to 
capture their prey 
Prey  Treatment Day 0 Day 3 Day 6 Day 9 Day 12 
Mean ±SE Mean ±SE Mean ±SE Mean ±SE Mean ±SE 
1 Control 5.95 1.6646 2.9 0.5754 3.6667 1.1939 6.7778 4.6838 2.5 0.9574 
1 toxic unit 2.8 0.388 99.9 74.94 410 160.69 201.8 150.92 307 298.26 
2 toxic units 9.4545 4.2836 232.5 102.7 294.12 140.38 109 96.185 4.6 1.1662 
4 toxic units 9.2727 3.2754 588.18 151.97 638.41 180.46 525.9 220.85 605.8 365.07 
2 Control 17.75 6.5578 6.65 0.955 8.5333 2.3882 11.333 7.0455 5.5 1.5 
1 toxic unit 6.45 0.6862 182 101.26 616.07 192.95 315 197.53 656.8 344.61 
2 toxic units 18.909 8.5442 475.59 137.9 428.29 150.76 341.6 193.83 9.8 3.3226 
4 toxic units 32.636 17.587 646.45 144.72 821.24 180.26 563.4 217.56 621.4 358.79 
3 Control 31.5 10.124 18.45 5.125 34.733 14.308 20.333 8.0691 9.75 2.3585 
1 toxic unit 13.75 2.8292 549.45 160.15 866.87 184.02 431.4 191.6 777.8 297.11 
2 toxic units 40.227 11.736 661.59 143.77 723.29 169.17 657.7 231.17 62 49.011 
4 toxic units 70.318 26.482 1054.2 134.31 1191.5 132.99 1071.4 218.37 646.2 349.11 
4 Control 242.35 110.13 42.45 14.47 270.13 116.87 51 20.277 18.75 3.8595 
1 toxic unit 222.15 108.94 860.65 162.4 1110 172.89 809.7 206.8 1093.2 234.67 
2 toxic units 339.82 114.25 914.27 140.31 924.47 165.34 777.5 212.65 613.8 361.79 
  4 toxic units 231.5 95.193 1298.6 99.131 1500 0 1115.8 195.72 1427.4 72.6 
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Time for hybrid striped bass to capture four consecutive prey during 6-day exposures to mixtures of fluoxetine and 
venlafaxine followed by a 6 day recovery period.  Values are presented as means ± standard error.  Data are 
presented graphically in figure 4.1, 4.2, and 4.3.  Toxic units represent 15 µg/L FLX and 25 µg/L VEN (1 toxic unit), 
30 µg/L FLX and 50 µg/L VEN (2 Toxic Units), 60 µg/L FLX and 100 µg/L VEN (4 Toxic Units). 
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Table A-5: Brain serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations for hybrid 
striped bass exposed to mixtures of fluoxetine and venlafaxine 
Prey  Treatment Day 0 Day 3 Day 6 Day 9 Day 12 
Mean ±SD Mean ±SD Mean ±SD Mean ±SD Mean ±SD 
5-HT Control 135.15 15.07 144.10 46.16 142.76 32.05 142.66 7.86 133.37 20.89 
1 toxic unit 135.15 15.07 94.58 23.36 105.70 14.51 126.42 21.21 117.94 21.18 
2 toxic units 135.15 15.07 101.35 13.83 110.43 14.76 99.48 10.65 120.61 5.17 
4 toxic units 135.15 15.07 105.38 20.95 103.23 11.53 106.31 14.63 120.70 10.38 
5-HIAA Control 55.55 8.55 54.96 15.92 55.54 7.29 49.61 4.37 42.23 4.75 
1 toxic unit 55.55 8.55 33.66 9.17 33.11 4.30 39.37 7.45 31.23 4.91 
2 toxic units 55.55 8.55 36.04 8.47 33.45 6.24 29.44 4.29 32.07 3.76 
  4 toxic units 55.55 8.55 34.18 8.33 34.48 4.41 28.14 4.77 34.49 5.19 
  
Concentrations of 5-HT and 5-HIAA (pg/µg protein) in the brains of hybrid striped bass exposed to mixtures of 
fluoxetine and venlafaxine for 6 days followed by a 6 day recovery period.  Values are presented as a mean ± 
standard deviation.  Data are presented graphically in figures 4.6 and 4.7.  1, 2 and 4 toxic units represent 
measured concentrations of 10.81 ± 1.36, 23.84 ± 2.63, and 55.47 ± 8.72 µg/L, respectively for fluoxetine and 
15.50 ± 2.02, 32.43 ± 3.21, and 74.30 ± 11.32 µg/L, respectively for venlafaxine. 
 
